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Abstract 
 
Jouni Johansson. Optimal schedule for home blood pressure 
measurements and clinical significance of the variability in home-
measured blood pressure and heart rate. National Institute for Health and 
Welfare (THL). Research 66, 178 pages. Turku, Finland 2011. 
ISBN 978-952-245-491-1 (printed); ISBN 978-952-245-492-8  (pdf) 
 
Hypertension is still a great burden in worldwide healthcare as it is one of 
the major causes of death globally. Accurate knowledge of the true blood 
pressure (BP) level is vital for optimal prevention and treatment of 
hypertension. Home BP monitoring has become popular due to cheap 
electronic devices. This thesis was set out to provide insight into building 
an optimal measurement schedule for home BP monitoring, and to 
evaluate how to increase the prognostic value of home monitoring by 
using variability parameters of home BP and heart rate measured over 
several days. 
The material was based on two studies. The Finn-home study consisted of 
a representative sample of the Finnish adult population (2106 individuals 
aged 41-74 years). Study subjects underwent a clinical interview, attended 
a health examination and measurements of home BP and home heart rate 
over 7 days. The Finn-home study included follow-up data of 
cardiovascular events. The second study population consisted of 228 
study subjects aged 34-64 years living in southwestern Finland who were 
randomly drawn from the population register, and of 236 newly 
diagnosed, yet untreated, moderately to severely hypertensive men and 
women, aged 35-54 years from southwestern Finland. Study subjects 
underwent a thorough clinical examination including echocardiography, 
measurements of microalbuminuria, ambulatory BP and 7-day self-
measured home BP. 
Based on the associations of ambulatory BP, target organ damage and risk 
of future cardiovascular events with home BP, the measurement accuracy 
of home BP increased with cumulative number of measurements. Most of 
the increase occurred during the first 3 days. 
In contrast to what the European guidelines (2008) suggest, 
measurements performed during the first day should not be discarded, as 
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it makes the measurement schedule more complex for the patient and the 
treating physician. The variability of home BP and heart rate predicted 
independently future cardiovascular events. Male gender, excessive use of 
alcohol, use of antihypertensive medication, past history of cardiovascular 
disease and sleep apnea were found to be independent determinants of 
elevated morning home BP in relation to evening BP. Old age, diabetes, 
history of cardiovascular disease and excessive use of alcohol were 
independent determinants of increased home BP variability. Young age 
and moderate use of alcohol were independently associated with 
increased home heart rate variability. 
On the basis of these studies it can be concluded that in order to reliably 
estimate true BP level, home BP should be monitored at least on 3 days, 
with duplicate morning and evening measurements. Currently, no 
consensus exists on recommended home BP measurement schedule. The 
new information in this thesis could be used to prepare a unified 
international guideline for home BP measurements. Since the variability 
of home BP and heart rate are independently associated with future 
cardiovascular events, home measurements performed on 7 days can 
provide additional information beyond the basic BP level. Knowledge of 
the underlying causes affecting morning and evening home BP 
differences, and of the variability of home BP and home heart rate, will 
enable healthcare professionals to focus cardiovascular disease-
prevention counselling for their patients. 
 
Keywords: home blood pressure, home heart rate, variability, 
cardiovascular risk 
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Tiivistelmä 
  
Jouni Johansson. Paras mahdollinen tapa kotiverenpaineen mittausten 
suorittamiseen sekä verenpaineen ja pulssin vaihtelun kliininen 
merkitys.Terveyden ja hyvinvoinnin laitos (THL). Tutkimus 66, 178 
sivua. Turku, Finland 2011. 
ISBN 978-952-245-491-1 (painettu); ISBN 978-952-245-492-8  (pdf) 
 
Kohonnut verenpaine on yksi merkittävimmistä ennenaikaisen kuoleman 
syistä maailmanlaajuisesti. Tarkka tieto todellisesta verenpainetasosta 
mahdollistaa tehokkaan ja tarkoituksenmukaisen kohonneen verenpaineen 
ehkäisyn ja hoidon toteuttamisen. Kotikäyttöön tarkoitettujen 
verenpainemittareiden helppo saatavuus on mahdollistanut kotona 
suoritettavat verenpainemittaukset. Hyvin tehty verenpaineen kotimittaus 
voi olla hyödyllisempi kuin ammattilaisen vastaanotolla tekemä ja sillä 
saadaan kerättyä suuri määrä tietoa. Tämän väitöskirjan tavoitteena on 
kehittää optimaalinen verenpaineen kotimittausmalli sekä arvioida kotona 
mitatun verenpaineen sekä sykkeen vaihtelun itsenäistä merkitystä 
valtimotautiriskin arvioinnissa. 
Väitöstutkimus koostuu kahdesta aineistosta. Finn-home tutkimus 
perustuu edustavaan suomalaiseen aikuisväestöotokseen (2106, 41-74-
vuotiasta henkilöä). Tutkimushenkilöt osallistuivat haastatteluihin, 
perusteelliseen terveystarkastukseen sekä 7 päivän verenpaineen ja 
sykkeen kotimittaukseen. Lisäksi Finn-home tutkimuksessa oli mukana 
seurantatieto henkilöiden sydän- ja verisuonitautitapahtumista. Toinen 
aineisto koostui 228 iältään 34-64-vuotiaasta Varsinais-Suomessa 
asuvasta henkilöstä, jotka poimittiin satunnaisesti väestörekisteristä, sekä 
236 iältään 35-54-vuotiaasta varsinaissuomalaisesta henkilöstä, joilla oli 
todettu kohonnut verenpaine. Tutkittavien perusteelliseen 
terveystarkastukseen kuului sydämen ultraäänikuvaus, virtsan 
mikroalbumiinin määritys, verenpaineen vuorokausirekisteröinti sekä itse 
tehdyt 7 päivän kotiverenpaineen mittaukset. 
Kotona mitatun verenpaineen yhteys verenpaineen 
vuorokausirekisteröintiin, kohde-elin vaurioon sekä sydän- ja 
verisuonitapahtumiin parani kotiverenpainemittausten lukumäärän 
kasvaessa. Suurin osa tästä paranemisesta tapahtui ensimmäisen 3 päivän 
aikana. Toisin kuin eurooppalaisissa suosituksissa (2008) todetaan, myös 
ensimmäisen päivän mittauksia voidaan käyttää, koska ensimmäisen 
päivän poisjättäminen tekee mittaussuosituksista vaikeaselkoisia. 
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Verenpaineen- ja sykkeen vaihtelut ennustivat itsenäisesti sydän- ja 
verisuonitapahtumia. Miessukupuoli, alkoholin suurkulutus, 
verenpainelääkitys, aikaisempi sydän- ja verisuonitauti ja uniapnea olivat 
suuremman aamu- ja iltaverenpaineen eron itsenäisiä selittäjiä. Korkea 
ikä, diabetes, aikaisempi sydän- ja verisuonitauti sekä alkoholin 
suurkulutus olivat suuremman verenpaineen vaihtelun itsenäisiä selittäjiä. 
Nuori ikä sekä alkoholin kohtuukäyttö olivat suuremman sykkeen 
vaihtelun itsenäisiä selittäjiä. 
Tämän tutkimuksen perusteella voidaan suositella luotettavan 
verenpainetason arvioimiseksi verenpaineen mittaamista kotona vähintään 
3 päivänä, kaksi kertaa aamulla ja kaksi kertaa illalla. Tällä hetkellä ei ole 
olemassa yhtenäistä kansainvälistä verenpaineen kotimittaussuositusta. 
Tämän väitöskirjan tuloksia voidaan käyttää uuden kansainvälisen 
verenpaineen kotimittaussuosituksen luomisessa. Seitsemän päivän 
kotimittaukset antavat lisätietoa verenpaineen ja sykkeen vaihtelusta ja 
ennustavat itsenäisesti sydän- ja verisuonitapahtumia. Tieto verenpaineen 
ja sykkeen vaihtelun taustalla olevista tekijöistä auttaa terveydenhuollon 
ammattilaisia sydän- ja verisuonitautien ehkäisyn ja hoidon 
toteuttamisessa.  
 
Avainsanat: kotona mitattu verenpaine, kotona mitattu syke, vaihtelu, 
sydän- ja verisuonitauti 
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Abbreviations 
 
AAMI The Association for the Advancement of Medical 
Instrumentation 
 
ASE American Society of Echocardiography 
 
ATC  Anatomical Therapeutic Chemical 
 
BHS British Hypertension Society 
 
BMI Body mass index 
 
BP Blood pressure 
 
CI Confidence interval 
 
CV Cardiovascular 
 
ECG Electrocardiography 
 
ESH European Society of Hypertension 
 
HR Heart rate 
 
ICD International Classification of Diseases, Injuries, and 
Causes of Death 
 
JNC Joint National Committee 
 
LVH Left ventricular hypertrophy 
 
LVM Left ventricular mass 
 
LVMI Left ventricular mass index 
 
RH Relative hazard 
 
SD Standard deviation 
1- Introduction 
THL  –- Research 66 14 Home BP and home HR monitoring 
 
 
 
1 Introduction 
The source of energy required to move blood in the circulation is 
provided by the pumping action of the heart (cardiac output). Blood 
pressure (BP) is a measurable end product for an individual’s 
physiological state consisting of the pumping action of the heart and 
peripheral vascular resistance. More accurately, this includes various 
factors controlling blood vessel calibre and responsiveness, factors 
affecting an individual’s fluid volume in the circulation and factors 
affecting cardiac output. All these factors are part of a complex 
interacting network where a change in one factor affects the others and 
also the whole system. When the total effect of these factors grows large 
enough, the result is seen as hypertension. The causes of hypertension are 
only rarely due to one reason, i.e. a function of only one gene, human 
internal BP regulation or a few environmental factors, but rather 
hypertension arises from a combination of a complex interacting network 
where each of the factors contribute a small effect on BP elevation. 
 
As there are many individual factors contributing to the development of 
hypertension, it has been shown that an elevated heart rate (HR) is an 
independent predictor in the development of hypertension [1-2] and, as 
well, a predictor of all-cause and cardiovascular (CV) mortality in 
particular [3]. These two facts make HR measurement an interesting and 
relevant matter to assess. In addition, the easiness in measuring HR at 
home, in conjunction with BP measurement, makes it even more useful 
from a clinical perspective. 
 
New studies have brought to light an emerging body of evidence about 
the causes of hypertension. The effects of environmental factors on BP 
elevation are of a different scale. Currently, the most remarkable 
environmental factor influencing the elevation of BP is high dietary 
sodium (by increasing fluid volume and preload + other mechanisms) [4]. 
The source of excess sodium in our diets can be tracked back to modern 
food-processing technology which adds sodium and removes potassium 
[5]. Obesity, high alcohol consumption and the use of tobacco products 
elevate BP as well. However, the link between BP elevation and these 
determinants is diversified (obesity by several mechanisms [6], alcohol by 
1- Introduction 
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increasing sympathetic activity  + other mechanisms [7] and tobacco by 
increasing plasma norepinephrine and epinephrine levels + other 
mechanisms) [8]. Stress has been associated as well with BP elevation (by 
increasing sympathetic nervous overactivity) [9], but it has been 
questioned whether or not it causes chronic hypertension [5]. 
In addition, there are several other reasons such as metabolic and 
hormonal disorders (diabetes, renal and other internal organ-related 
causes), physical inactivity, arterial stiffness (and other vascular changes 
altering the arterial structure), sex hormones and minerals, all of which 
elevate the CV risk [10]. 
There are as well genetic factors which have an influence on BP 
elevation. Several genetic factors elevating BP have been discovered 
including ethnical differences [11] (e.g. increased salt sensitivity in 
blacks), obesity-related BP elevation [12] and deletion of angiotensin 
converting enzyme gene [13]. Since in some studies it has been found that 
the offspring of hypertensive parents will also develop hypertension [14], 
there might still be undiscovered genetic forms of hypertension. Genetic 
studies can help to single out genetic from environmental factors [14], a 
matter which is crucial in selecting the appropriate therapy for subjects 
suffering from hypertension. 
 
Regardless of the etiology, hypertension can be classified as primary 
(essential) hypertension where the cause of blood pressure (BP) elevation 
is unknown or as secondary when the mechanisms underlying behind BP 
elevation are known. Over ninety-percent of the cases are classified as 
primary hypertension [15-16]. However, the frequency of secondary 
hypertension will progressively increase in time, as improved diagnostic 
procedures are introduced into clinical use, and as new specific genetic 
and environmental factors are identified as a cause of hypertension. 
 
Since the prevalence of hypertension in the adult population is currently 
26%, and its prevalence is predicted as increasing by 60% by the year 
2025 [17], it continues to be an important health-care issue. This has been 
acknowledged as well by the World Health Organization [18]. In their 
report, they state that CV diseases are increasing in both developed and 
developing countries and that the risk factors connected to CV diseases 
are tobacco use, alcohol consumption, high cholesterol concentrations, 
high BP levels, low intake of fruit and vegetables, insufficient physical 
activity and elevated BMI. Of these CV risk factors, high BP ranks at the 
top together with alcohol. 
1- Introduction 
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The prevalence of hypertension in the Finn-Home study (a sub-study of 
Health 2000 study) by age groups is presented in Figure 1. As enormous 
amounts of data are currently gathered through BP measurements, the 
most important goal for the time being is to ensure optimal and reliable 
BP monitoring, as well as optimal and effective utilization of BP 
measurement data. 
 
Since the prevalence of hypertension is at a high level in the population 
and no decline is in view more robust measures should be implemented. 
The current challenges are to identify those who are at the risk of 
complications caused by an elevated BP, and to get subjects with an 
elevated BP to follow recommended lifestyle guidance even in the 
prehypertension stage. In practice, this means actively promoting home 
BP monitoring at the population level to reach hypertensive and 
prehypertensive subjects and to accurately follow and adjust an 
implementation of lifestyle guidance and antihypertensive medication. 
 
 
 
 
Figure 1. The prevalence of hypertension by age groups in the Finn-home 
study. 
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Table 1. JNC-7 criteria for hypertension. Table adapted from [10] 
 
BP classification 
Systolic BP 
(mmHg) 
Diastolic BP 
(mmHg) 
Normal <120 and <80 
Prehypertension 120-139 or 80-89 
Stage 1 hypertension 140-159 or 90-99 
Stage 2 hypertension !160 or !100 
2 - Review of the literature 
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2 Review of the literature 
2.1 Home blood pressure and home heart rate 
monitoring 
 
For as long as BP has been measured in clinical practice, the auscultatory 
technique has been the method of choice for the diagnosis and follow-up 
of hypertension. The first automated home BP monitors as well as the 
ones used in the office were based on auscultatory technique whereas 
currently available home monitors are based on oscillometric 
measurement technique [19]. 
 
The introduction of electronic oscillometric home BP monitors and the 
progressive growth of self-measurement of BP at home have challenged 
conventional office BP measurement since the latter has some limitations 
in assessing hypertension and cardiovascular (CV) risk [20]. During the 
recent decades, cheap and reliable electronical home BP monitors have 
increasingly found their way to many households as self-measurement of 
BP has become more popular [21]. According to the above mentioned 
German study, only in a small amount of patients had the physician 
encouraged them to perform home BP self-measurements (8%, year 
2007). In most of the cases, the impetus was a self-initiative from the 
patient’s side for performing home measurements (78%, year 2007) [21]. 
A change is needed in the way of thinking in promoting home BP 
monitoring at population level since the international guidelines have, 
until now, emphasized office and ambulatory BP monitoring over home 
BP monitoring. 
 
BP can be monitored at home using either a conventional or an 
ambulatory BP monitor. However, ambulatory BP monitoring has only 
found limited clinical use because of its inconvenience and expense 
compared to home BP monitoring [22]. The barrier between ambulatory 
and traditional home BP monitoring is slowly fading out as devices with 
the capacity to perform measurements at predetermined times are being 
introduced on the market [23], although at present they are not widely 
commercially available. In addition, however, home BP monitors with 
embedded monitoring guidelines based on the international 
2 - Review of the literature 
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recommendations for monitoring home BP are also being introduced on 
the market [24]. 
 
Home HR is as well, an extremely useful measure, as it is easily achieved 
in conjunction with home BP measurement. Several studies have found 
strong associations between BP and HR [25-26]. In addition, there is a 
growing body of evidence that HR is a predictor of hypertension and also 
a predictor of all-cause as well as CV mortality [1, 3]. The utilization of 
home HR in practice is, however, still unclear as its role has not yet been 
clearly demonstrated in population studies. 
 
In this thesis, I shall focus on how best to monitor home BP. This 
includes determining the optimal measurement schedule based both on a 
cross-sectional approach and prognostic data, as well as, factors affecting 
the difference between morning and evening home BP, and home BP/HR 
variability. The prognostic value of home BP/HR variability will also be 
covered in this thesis. 
 
2.2 Technical background of home blood pressure 
and heart rate monitoring 
 
When the home BP monitors were first introduced into clinical use the 
majority of monitors were aneroid sphygmomanometer devices [27]. 
Currently, the device considered as the standard for performing home BP 
measurement, is a validated automated oscillometric device that records 
BP from the brachial artery [28]. However, the oscillometric method was 
first introduced in 1876 [29]. The first commercially produced automated 
oscillometric device named Dinamap was not on sale till 1976 [30]. It 
measured only mean arterial pressure. Mean arterial pressure was selected 
since it is theoretically the most robust measurement (compared to 
systolic or diastolic pressure) [31]. Several years later the introduction of 
low-cost microprocessors and pressure transducers allowed the use of 
other measurement parameters such as systolic and diastolic BP [31]. 
 
The oscillometric device’s main component and the “workhorse” taking 
care of the measurement operation is the cuff and its pneumatic 
connection to the main unit together with pump and valve systems. There 
can be one or two hoses that connect the cuff pneumatically to the main 
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instrument. Today the oscillometric devices use a single pneumatic circuit 
to inflate and deflate the cuff [31]. 
 
The cuff is used to compress a limb and its vasculature so as to be able to 
identify systolic and diastolic blood pressure values from cuff pressure 
[31]. The inflated cuff compresses the arteries in the forearm so that no 
blood flow is occurring in the arteries. When the pressure in the cuff is 
gradually decreased, at some point, the blood begins to flow in the 
arteries causing oscillations. The point where the artery begins to “emit” 
the pulsations is where the home BP monitor defines the “maximum BP” 
called systolic BP. The deflation of the cuff continues until the device can 
no longer detect oscillations. Pressure in the cuff is sensed by the solid-
state pressure transducer and thereafter the signal is postprocessed before 
it is digitized by analog-to-digital converter. The point where the 
oscillations disappear, the device defines as the diastolic BP (Figure 2). 
The microprocessor controls the inflation and deflation process of the cuff 
and in the end interprets the digital signal. 
 
Every manufacturer of the oscillometric device uses their own algorithm 
in calculating the correct systolic and diastolic BP values. This 
information is not publicly available which makes it impossible to 
thoroughly compare the accuracy of different home BP monitors. 
  
The oscillometric device technique is considered to be cheap and reliable 
in use compared to other techniques [22]. There are already devices 
available that have the capacity to store home BP readings in the memory 
and send them electronically to the physician [32-33]. This further 
improves patient compliance, BP control and eliminates delays between 
the patient and the physician. However, the most important issue in 
selecting a proper home BP monitor is the accuracy of the device. The 
accuracy of the home BP monitor is ensured by a proper validation 
protocol which is covered in detail in the next section. 
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Figure 2. The figure represents a simplified model on how the 
oscillometric blood pressure device determines systolic and diastolic 
blood pressure. The upper lines indicate the pressure in the blood 
pressure monitoring cuff when it is gradually deflated. The lower bars 
indicate the oscillations detected by the blood pressure monitor. The first 
detected oscillation is recognized as systolic blood pressure and the last 
oscillation the device can detect, is considered to be the diastolic blood 
pressure. 
2.3 Validation of home blood pressure devices 
2.3.1 Validation protocols 
 
BP determination continues to be one of the most important 
measurements in all clinical medicine but unfortunately it is one of the 
most inaccurately performed. Since deviations of only a few mmHg may 
determine whether active measures for lowering the BP are needed or not, 
accurate measurement of BP is essential to assess the BP related CV risk 
correctly and to be able to guide the patients with appropriate medication 
and lifestyle management. For the individual consumers (both medical 
professionals and laymen), the accuracy of the BP measurement device 
should be the first priority when selecting a BP monitoring device. The 
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three most widely used independent validation protocols are those of the 
British Hypertension Society (BHS) protocol [34], The Association for 
the Advancement of Medical Instrumentation (AAMI) protocol [35] and 
the International Protocol of the European Society of Hypertension (ESH) 
[36]. Between years 2002 and 2009, 104 validation studies had been 
conducted using the ESH protocol, 36 using the BHS protocol and 28 
using the AAMI protocol [37]. 
In addition, the home BP monitors should be checked for validity at least 
every second year [22]. Both the BHS and AAMI protocols require an 
assessment based on 85 subjects, with three BP measurements recorded 
for each person, for a total of 255 measurements. The idea in both 
validation protocols is that each monitor-reading  is compared with the 
observer’s corresponding reading (performed by a trained human 
observer using a mercury column sphygmomanometer) and the difference 
(error) is calculated [38]. There are, however, some differences between 
the validation protocols regarding the method of the validation of BP 
monitor-accuracy [38]. The international protocol of ESH is a simplified 
and rationalized version based on the BHS and AAMI protocols. The 
main procedures that have been included into the ESH protocol include 
elimination of pre-validation phases, improving observer recruitment and 
training, use of simultaneous or sequential comparisons, minimizing 
observer error during validation and reduction in the number of subjects 
recruited, relaxing the range of blood pressures, eliminating ‘hopeless’ 
devices at an early stage of the validation process, simplifying the 
validation results, validation algorithm integrity and design modification, 
diminishing intra-subjects variability by excluding subjects with 
extremely high or low BPs and taking account of the suitability of the 
device for individuals [36]. The more detailed differences between ESH 
and other protocols can be found in the ESH Working Group paper [36]. 
 
2.3.2 Limitations of the validation protocols 
 
Consensus reports have suggested that a home BP monitor can be 
considered valid if it is accurate to within 5 mmHg. This is determined by 
comparing several readings (usually 255 measurements of 85 patients for 
AAMI and BHS validation) by an automated monitor and by comparing 
readings achieved by using a manual sphygmomanometer and a human 
listener (with a stethoscope) [38]. Although the international validation 
protocols offer the basis for a unified consensus for home BP monitors, 
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they have some crucial failures in assessing the error of the home 
monitors. That is, they analyse the error of the 255 individual readings 
and not the errors observed in 85 participants. Therefore, the protocols do 
not take account of the between-individual variability in the validation 
process. Due to this reason, a home monitor can be more accurate for 
some individuals than for others. It has been recommended that the 
validation process should contain two stages: first, the BP monitor should 
be validated at the population level, and second, the same monitor should 
be validated for the individual user [38]. 
  
Health care personnel and individuals can find a continuously updated list 
of currently validated monitors for self-measurement of BP at 
www.dableducational.org. 
 
2.4 Morning and evening measurements in home-
measured blood pressure 
 
Current international guidelines recommend measuring home BP twice 
every morning and evening. However, BP is not a constant variable and 
variation throughout the day occurs. In a healthy, normotensive European 
general population evening home BP is higher than morning home BP 
[39-42]. In contrast to studies made in Europe, Japanese population 
studies show that in the general population morning home BP is higher 
than evening home BP [43-46]. Because of the differences in populations 
and reasons behind these phenomena, it is important to know the factors 
affecting the morning-evening difference of home BP. Harmful effects of 
high morning BP (morning surge) have been linked to CV (strokes) 
diseases independent of the 24-hour BP level  [47] and to sleep apnea 
[48], but the factors affecting the difference of morning and evening BP 
have remained partly unknown. 
Some studies have tried to assess the characteristics and factors affecting 
morning-evening difference [43-46]. However, more detailed information 
is needed especially about the lifestyle factors affecting the morning-
evening difference. The knowledge of the exact lifestyle factors affecting 
this difference would help physicians to easily recognize individuals by 
their morning and evening BP profile. 
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2.5 Variability in home-measured blood pressure and 
heart rate 
 
BP and HR are not constant variables and significant fluctuations occur 
throughout the day and also during longer periods of time. The variation 
in home-measured BP and HR can be caused by two reasons, firstly by 
the errors of the home BP monitor, and secondly by the physiological 
variation in humans. Variation of BP and HR are affected by 
physiological factors: e.g. respiration, emotions, physical exercise, 
activity of the alimentary system, hormonal regulation and fluid balance 
(absolute volume and concentration), and by extrinsic factors such as: 
tobacco products, alcohol, the atmosphere, temperature, pain, 
antihypertensive drugs, as well as other lifestyle factors [49]. In addition, 
BP and HR variations can be classified as ultra-short time (beat-to-beat), 
intraday (between daily measurement occasions), diurnal (morning-
evening) and long-term (e.g. day-to-day or seasonal) BP or HR 
variability. 
 
The harmful effects of high (home) BP and HR on health are well known, 
but the factors affecting the variability of home-measured BP and HR 
have, however, remained unclear. In addition, the knowledge of the 
prognostic value of the variability in home-measured BP and HR are still 
imperfect, as no studies exist based on the current recommended 
monitoring guidelines (including 7 days consecutive BP monitoring with 
two morning and two evening measurements) [49-50]. 
 
The significance of the variability in ambulatory BP and HR has been 
well studied and the results have provided evidence that the variability of 
BP and HR have both diagnostic and prognostic value [51-59]. Different 
patterns in BP and HR variability have been associated with sympathetic 
nervous regulation, alcohol use, target-organ damage and CV events [51-
59]. However, the significance of the variability in home-measured BP 
and HR has remained quite unknown. Currently, only one study has been 
made about the prognostic value of day-by-day home BP variability in 
which greater day-by-day morning home BP variability predicted CV 
mortality [60]. However, no studies have been made assessing the value 
of the variability in home-measured BP and HR according to the 
recommended current international guidelines [49-50]. Therefore, the 
prognostic value of the variability in home-measured BP and HR have 
until now remained unclear. 
2 - Review of the literature 
THL  –- Research 66 25 Home BP and home HR monitoring 
 
 
2.6 Benefits of home blood pressure monitoring 
2.6.1  Home-measured blood pressure advantages over clinic 
and ambulatory blood pressure monitoring 
 
The use of self-measurement of BP at home has become widely popular 
because of the easiness of its use compared to ambulatory recordings and 
it obtains better assessment for the severity of hypertension and prediction 
of risk than by using clinical measurements [20]. Measuring blood 
pressure at the clinic is limited by the small number of readings usually 
taken and the poor estimate of the individual’s true BP level. 
Home BP measurement is as reliable as ambulatory BP measurement in 
assessing hypertension and target-organ damage [61-63]. However, for an 
extra benefit, ambulatory measurement even provides information of the 
24-hour BP profile as well as short-term variation. Especially nighttime 
BP has been found to be a better predictor of CV risk than daytime BP 
[64-67]. Ambulatory BP monitoring has only a limited clinical use 
because it is inconvenient and expensive. Therefore, ambulatory 
recordings are best suitable for specific group of individuals. This 
includes individuals who are unable to perform home BP measurements 
according to the recommended guidelines. In clinical practice, ambulatory 
and home BP monitoring complement each other. 
 
Home BP measurement provides more accuracy over clinical BP by 
easily enabling a large number of home readings [68]. In addition, home 
BP readings are not affected by white-coat effect [69] and are therefore 
suitable for subjects suffering from ‘white-coat effect’. Home BP 
monitoring is often also the best available method for assessing BP in 
special groups of individuals, such as in subjects with diabetes, chronic 
kidney disease, elderly individuals, as well as in pregnant subjects [49-
50]. Furthermore, home BP measurements can be used effectively to 
monitor the antihypertensive drug efficacy [70-72]. Using home BP 
monitoring can also improve control of hypertension by giving an active 
role to the individual himself [73]. Coupling home BP monitoring with 
telemedicine can further improve hypertension control [74-76]. 
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2.6.2 Economical benefits 
 
Home BP monitoring makes it possible to gather large amounts of data 
easily and at a low cost compared to other methods (office or ambulatory 
monitoring) [77]. Moreover, in several prognostic studies, home BP 
monitoring has been proved to be as good as ambulatory BP monitoring 
and even better than office monitoring [20, 61-63]. In two studies 
examining the compliance of home BP monitoring it has been shown that 
possession and use of home BP monitor improves patient knowledge 
concerning BP control, enabling better decisions and promoting 
confidence in BP management [78-79]. Furthermore, it has been found 
that subjects who had home BP monitoring had lower BP than those who 
did not [80]. 
Even though home BP monitoring has been adapted for use worldwide, 
its cost-effectiveness has not been thoroughly investigated. Some studies 
on that subject have, however, been made [81-82]. Home BP monitoring 
has a huge potential for cost savings in medical economy since it can 
prevent unnecessary treatment of subjects having the white coat 
phenomenon, and may curb unnecessary office visits [81-82]. However, 
home BP monitoring can also lead to worse BP control compared to 
office BP monitoring [82]. 
 
2.6.3 Individual benefits 
 
Today, there is a growing interest in finding new ways of helping people 
to become interested in their own health not just momentarily but 
throughout their whole life. This means that medical professionals should 
be familiar with the newest strategies available in preventive health care. 
One intervention in achieving effective health advances is to get patients 
sympathetic to the idea of self-care. Great strides are made when patients 
are taking an active part and give their own contribution to their health 
promotion. By focusing on self-care and prevention of CV diseases, home 
BP monitoring offers remarkable individual benefits over other 
techniques [75]. 
The American Heart Association, the American Society of Hypertension 
and the Preventive Cardiovascular Nurses Association have also made a 
joint scientific statement concerning both the economical and individual 
benefits of home BP monitoring [50]. 
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2.7 Limitations of home blood pressure and heart 
rate measurements 
 
Home BP monitoring provides a robust method for reliably assessing BP 
level in the general population and that is why there is a widely accepted 
common agreement that home BP monitoring should be used for all 
patients with a BP problem. However, there are still some marginal 
limitations where home BP monitoring is not suitable. These limitations 
include specific group of individuals: subjects who are unable to follow 
instructions of home BP self monitoring (e.g. demented subjects), 
subjects who are easily stressed about performing self measurements, 
subjects with atrial fibrillation or other arrhytmias (when the oscillometric 
device cannot perform the measurements reliably), and when 24h BP 
profiles are needed, that is, quantification of nocturnal BP (dippers and 
nondippers) and short-term BP variability. Moreover, there might be 
some user-related techniques that can cause difficulty for an oscillometric 
device to perform BP measurements correctly. These are cuff-related 
causes (incorrect cuff size, incorrect cuff application and leaking cuff or 
hoses) and patient-related causes (cuff not at heart level and patient not 
instructed to relax properly before measurement) [31]. The features 
between home, office and ambulatory BP monitoring are compared in 
Table 2. 
 
Despite the fact that home BP monitoring provides a valid representation 
of the patient’s true BP level, more focus should be put on the patient’s 
valid documentation of home BP in clinical care [83]. In addition, 
although there is an increasing rate of self-monitoring of BP [21], only 
60% of the hypertensive patients in Finland use home BP monitoring 
regularly [84]. Therefore, more effort should be focused on the promotion 
of proper home BP monitoring use and on improving the accessibility of 
home BP monitoring data. At the same time, to ensure reliable home BP 
monitoring, doctors should be aware of recommending only validated 
home monitors to their patients. 
 
As there is a growing body of evidence that an elevated HR is as well a 
risk-factor for hypertension and CV mortality [1, 3], the value of home 
HR measurements have not yet been recognized. As home HR 
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measurement is easily performed in conjunction with home BP 
monitoring, the obstacle to its current utilization has been the lack of 
studies giving proof of its value. 
 
Table 2. Comparison between features of home, office and ambulatory 
monitoring 
Feature 
Home 
monitoring 
Office 
monitoring 
Ambulatory 
monitoring 
Treatment assessment Easy Easy Laborious 
White coat effect No Yes No 
Reproducibility High High High 
24-hour recording Possible No Yes 
Morning measurement Yes Difficult Yes 
Evening measurement Yes Difficult Yes 
Long term variability Yes Difficult Difficult 
Day-by-day variability Yes Difficult Difficult 
Beat-to-beat variability No No Yes 
Prognostic value of CV 
events High Low High 
Patient compliance High Low Low 
Hypertension control High Moderate Low 
Cost Low Moderately high High 
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2.8 Current international recommendations for home 
blood pressure monitoring 
 
The European Society of Hypertension guidelines, the Japanese Society 
of Hypertension and the American Heart Association statement for home 
BP monitoring currently recommend that home BP should be monitored 
preferably for 7 days with two morning and two evening measurements 
[49-50, 85]. The average of all values should be used with the exception 
of the first day values which should be discarded. It has also been 
discussed whether the first-day home BP values should be discarded or 
not [86]. The guidelines recommend discarding the first-day home BP 
measurements as they may be higher and more unstable (higher variation) 
than the measurements performed on the following days [49-50, 86]. The 
same statement and the guidelines also give monitoring-preparation 
recommendations for individuals performing home BP measurements. 
Tobacco or caffeine containing products should be avoided for 30 
minutes before the measurements, and the measurements should be 
performed after 5 minutes of rest. The more specific recommendations 
can be read in the above-mentioned references. Also available is a concise 
version of the current European Society of Hypertension guidelines 
intended to be used by clinicians in daily practice [87]. 
 
The American Heart Association statement and The European Society of 
Hypertension guidelines provide a good practical methods of how to 
evaluate and deal with different kinds of patient types, e.g. subjects with 
diabetes, elderly, chronic kidney disease, pregnant subjects and subjects 
using antihypertensive medication [49-50]. This is highly important since 
home BP monitoring is being increasingly used in many countries and 
among different subjects. 
 
The current statement and the guidelines also take account of the cost-
effectiveness of home monitoring versus other techniques. 
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2.9 Evaluating blood pressure and cardiovascular 
risk in clinical practice 
 
According to current international guidelines [49-50] the target goal for 
home BP is <135/85 mmHg or <130/80 mmHg in high-risk patients (only 
American guidelines). When home BP is measured according to currently 
recommended guidelines using a validated measurement device, the 
patient risk evaluation can be performed correctly. 
Accurate and real home BP level achieved by carefully following the 
measurement protocol and combined with a major risk-factor profile of an 
individual patient (made through examining medical history, physical 
examination, laboratory and other necessary diagnostic tests) gives a 
thorough image of the risk which the patient is exposed. 
The most essential CV related risk factors including hypertension are old 
age (>55 years for men and >65 years for women), diabetes mellitus, a 
family history of premature CV disease (<55 for men and <65 for 
women), obesity, physical inactivity, dyslipidemia, and probable target-
organ damage (LVH, microalbuminuria, myocardial infarction, heart 
failure, stroke, chronic kidney disease) [10, 88]. 
By using the above-mentioned methods in the evaluation of the CV risk 
of an individual patient provides the physician ability to take correct 
measures on CV risk-management (reveal identifiable individual causes 
of hypertension, apply antihypertensive therapy if necessary and give CV 
risk prevention counselling). 
CV risk evaluation can either be based on surrogate end-points including 
assessment of LVH (using echocardiography or ECG), microalbuminuria 
and carotid ultrasonography or CV events data (morbidity or mortality). 
Surrogate end-points are often easier to assess, but mortality data provide 
better risk-prediction accuracy.  
Computer-based calculators for CV risk evaluation have been developed 
by several instances (e.g. FINRISKI and Framingham). They are based on 
the risk-factor characterization of the patient, that is: age, gender, 
laboratory data, BP level and family history of CV disease. These 
calculators make the evaluation of CV risk possible in clinical practice in 
a fast and efficient way. However, for the time being a disadvantage 
related to these calculators are that their database is based on the office 
BP measurements and not on home BP measurement data. In order to 
efficiently and reliably implement a CV risk calculator, it should be based 
on home BP measurements, with up-to-date CV risk-factor data. 
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2.10 Goals of home blood pressure monitoring 
 
The most fundamental goal of home blood pressure monitoring is to 
diagnose those who are at the greatest CV risk. This is not only done by 
measuring the BP level itself but also by utilizing other information 
obtained from home BP measurements (BP and HR variability and HR 
level). Since the current guidelines on home BP monitoring are still far 
from perfect, in this thesis I shall focus on how best to monitor home BP. 
This includes determining the optimal measurement schedule based both 
on the cross-sectional approach and on the prognostic data, as well factors 
affecting the difference between morning and evening home BP, and 
home BP/HR variability. The prognostic value of home BP/HR variability 
will also be covered in this thesis. 
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3 Aims of the study 
This thesis was set out to build an optimal measurement schedule for 
home blood pressure monitoring, and to investigate the use of home BP 
variability and home HR variability in primary health care. 
 
The specific goals were: 
 
1. To find an optimal schedule for home blood pressure 
measurement based on the association between home blood 
pressure and target-organ damage and between home blood 
pressure and ambulatory blood pressure measurements. 
 
2. To find an optimal schedule for home blood pressure 
measurement based on prognostic value. 
 
3. To examine the determinants affecting morning and evening home 
blood pressure difference. 
 
4. To study the determinants affecting the variability of home-
measured blood pressure and heart rate. 
 
5. To assess the prognostic significance of variability in home-
measured blood pressure and heart rate. 
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4 Materials and methods 
In the following paragraphs the materials and methods of Studies I-V are 
covered. Studies II-V are based on the Health 2000 studies where as 
Study I is based on 2 cohorts consisted of the general population and the 
hypertensive population. 
4.1 General 
 
Figure 3 describes the home BP measurement scheme used in Studies I-V. 
Home BP was measured on 7 consecutive days, twice in the morning and 
twice in the evening, yielding altogether 28 measurement points. 
Variability variables are only used in Studies IV and V. The BP/HR 
variability variables are based on the calculation of SD. The formulas of 
morning minus evening home BP/HR variability, first minus second 
measurement of home BP/HR variability and morning/evening day-by-
day home BP/HR variability are presented below. The parameters of 
home BP/HR variability have been chosen so that they represent 
clinically relevant variability components. 
 
 
Figure 3.  Home blood pressure measurement schedule. Numbers inside 
the circles indicate the individual measurement points. 
 
Morning minus evening home BP/HR variability 
 
SD of the following differences between morning and evening measurements 
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SD of the following differences between the first and second measurements 
 
Day-by-day home BP/HR variability 
 
SD of the following mean values between seven individual days 
 
 
Morning day-by-day home BP/HR variability 
 
SD of the following mean values between seven individual days morning measurements 
 
 
Evening day-by-day home BP/HR 
 
SD of the following mean values between seven individual days morning measurements 
 
 
= mean of n number of individual home BP/HR measurement points. Subscript of 
k indicates the individual measurement order number (from 1 to 28). 
 
4.2 Study I 
4.2.1 Study population 
 
The study population consisted of 2 cohorts. The study sample for the 
first cohort consisted of 340 men and women aged 34!64 years living in 
southwestern Finland who were randomly drawn from the population 
register. 275 subjects (80.9%) agreed to participate in the study. After 
excluding subjects with diagnosed coronary artery disease, 
cerebrovascular disease, insulin-treated diabetes mellitus, 
hemodynamically significant valvular disease, pregnant women, subjects 
with antihypertensive medication and those who had performed under 14 
home BP measurements, the first study cohort consisted of 228 subjects. 
 
The study sample for the second cohort consisted of 252 newly diagnosed, 
but yet untreated, moderately to severely hypertensive men and women, 
aged 35!54 years. These patients were referred to the study by general 
 
First minus second home BP/HR variability 
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practitioners and internists within the primary and occupational health 
services in southwestern Finland. The inclusion criteria were a systolic 
BP consistently between 180 and 220 mmHg, or a diastolic BP between 
100 and 120 mmHg, as measured within the primary healthcare system. 
Recruitment BP was defined as the mean of the last 2 measurements 
made by the primary healthcare staff. Patients with coronary artery 
disease, cerebrovascular disease, insulin-treated diabetes mellitus, or 
hemodynamically significant valvular disease and pregnant women were 
excluded from the study. In addition, subjects who had performed under 
14 home BP measurements or had started taking antihypertensive 
medication before the study were excluded. The second study cohort 
consisted of 236 subjects. 
 
The two cohorts were analysed both separately and together (n=464). The 
study was conducted in compliance with the Second Declaration of 
Helsinki and was approved by the ethical committee of the Social 
Insurance Institution of Finland. All the subjects gave their informed 
consent. 
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4.2.2 Flow of Study I 
The flow chart of the population in Study I is presented in Figure 4. 
 
Figure 4. A flow chart of the study population in Study I. 
* Subjects who had been diagnosed as having coronary artery disease, 
cerebrovascular disease, insulin-treated diabetes mellitus, 
hemodynamically significant valvular disease, pregnant women, subjects 
with antihypertensive medication and those who had performed under 14 
home BP measurements were excluded. 
† Patients with coronary artery disease, cerebrovascular disease, insulin-
treated diabetes mellitus, or hemodynamically significant valvular 
disease, pregnant women and patients who had performed under 14 home 
BP measurements were excluded. 
4.2.3 Urine microalbumin 
 
24-h urine was collected for albumin measurements. The measurement 
range for albumin was from 0.5 to 16 mg/dL and the amount of albumin 
was measured by nephelometry (Orion Diagnostica 667560, Orion corp., 
Finland). 
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4.2.4 Echocardiography 
 
To assess the left ventricular mass (LVM) the echocardiography 
examinations were successfully performed for 494 subjects using 2-
dimensional controlled M-mode examinations (Aloca SST-860 color 
Doppler ultrasonoscope and a 3.5 MHz phased-array transducer). 
Measurements were performed according to the recommendations of the 
American Society of Echocardiography (ASE) [89]. Left ventricular 
echocardiograms were measured at the tips of mitral leaflets and averaged 
over 3 heart cycles. ASE cube left ventricular mass (g) was calculated as 
follows: 1.05 x [(interventricular septal thickness in diastole + left 
ventricular internal dimension in diastole + posterior wall thickness in 
diastole)3 – (left ventricular internal dimension in diastole)3]. Corrected 
left ventricular mass (g) was calculated by the Devereux equation 0.8 x 
(ASE cube left ventricular mass) + 0.6 [90]. 
The LVM index (LVMI) in this study was defined as [LVM (g) / height 
(m)]. 
 
4.2.5 Home blood pressure measurements 
 
The BP self-measurements were performed at home on 7 consecutive 
days, twice in the morning and twice in the evening by using a validated 
automatic oscillometric device (Omron HEM 705C, Omron Matsusaka 
Co, Japan) [91]. The participants measured their blood pressure between 
0600 and 0900h in the morning and between 1800h and 2100h in the 
evening. The two measurements were performed at 1!2 minutes intervals. 
The participants received oral and written instructions on how to perform 
the home BP measurements correctly and the 7-day home BP monitoring 
commenced on the following morning. The mean number of home BP 
measurements was 27.5 ± 1.6. 
 
4.2.6 Ambulatory blood pressure monitoring 
 
Ambulatory BP was recorded using an automatic Suntech Accutracker II 
(Suntech Medical Instruments, Raleigh, NC, USA) unit set to take 
measurements every 15 minutes during the daytime (between 0600 and 
2300h) and every 30 minutes during nighttime (between 2300 and 0600h). 
Measurements were performed according to the guidelines of the Berlin 
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Consensus Document [92]. Mean 24-hour ambulatory BP was used for all 
analyses. 
 
4.2.7 Statistical analysis  
 
The statistical analyses were performed with SAS software version 9.1 
(SAS Institute, Cary, NC, USA). The means of the systolic BP and 
diastolic BP were calculated both separately and cumulatively for 
individual days. Before the statistical analyses were performed, the 
skewed distribution of urine microalbumin was corrected by a logarithmic 
transformation (natural logarithm). Pearson’s correlation was used to 
describe the association between continuous variables. The comparisons 
between the correlations were performed using SAS Calis procedure. 
 
4.3 Studies II-V 
4.3.1 Study populations 
 
These studies are part of the multidisciplinary epidemiological survey, the 
Health 2000 Study, which was performed in Finland from autumn 2000 to 
spring 2001. The Health 2000 Study population was a stratified two-stage 
cluster-sample composed of 8028 individuals randomly drawn from the 
population register representing Finnish adults aged 30 years or over. The 
details of stratification and sampling procedures have been previously 
reported [93]. 
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Figure 5. Study locations of the Health 2000 study are marked in dark 
grey on the map of Finland. 
 
There were 4934 individuals aged 41—74 years, of which 4148 (84%) 
agreed to participate in the interview and also attended the health 
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examination. Finally, 2106 individuals participated in the home BP 
measurement substudy (Finn-home study). The study participants with 
arrhytmias such as atrial fibrillation and flutter were not included in the 
Finn-home study. Home measurement of BP was not performed on all 
individuals willing to participate because of the limited number of home 
monitors (approximately 800). The home monitors were given to the 
study participants in random order. The study protocol of the Health 2000 
Study was approved by the Epidemiology Ethics Committee of the 
Helsinki and Uusimaa hospital region, and all participants gave their 
signed informed consent. 
 
Subjects of the Finn-home substudy who had a missing health 
examination or interview data (n=25 in Study II; n=153 in Studies III and 
IV; n=191 in study V), had not performed 14 or more valid home 
measurements of BP (n=38, in Study III), had not performed 14 or more 
valid home measurements of BP or HR (n=50, in Studies IV and V), or 
had incomplete laboratory values (n=11, in Studies III, IV and V) were 
excluded from the study. After removing participants with one or more 
exclusion factors, the study population consisted of 2081 (in Study II), 
1919 (in Study III), 1908 (in Study IV), and 1869 (in Study V) 
participants. 
 
Nonparticipants consisted of those who agreed to go to the interview and 
attended the health examination, but did not participate in the home BP 
measurement study or were excluded from the participants’ group. 
Nonparticipants differed slightly from the participants (aged 41-45 years 
and 45-74 years) included in the Finn-home substudy, in terms of age, 
systolic office BP, use of antihypertensive medication and prevalence of 
diabetes (Table 3). Furthermore, participants aged 41-74 years differed 
from nonparticipants in terms of BMI. 
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Table 3. Participants versus nonparticipants. 
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4.3.2 Flow of the studies (Studies II—V) 
The flow chart of the population in Studies II-V is presented in Figure 6. 
 
Figure 6. A flow chart of the study population in Studies II-V. 
* There were 94 participants aged <45 years (2 subjects aged 41 years, 1 
aged 42 years and 91 aged 44 years). 
† Some excluded subjects have more than one exclusion factors missing. 
‡ Less than 14 home BP and/or home HR measurements performed.
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At an initial health interview at the participant’s home, basic background 
and sociodemographic information, information about health and illnesses 
as well as the use of medication was gathered by centrally-trained 
interviewers. Individuals who were willing to participate in the Finn-
home substudy received home monitors for measuring BP and HR during 
the week after the health interview. A physical examination was 
performed on each participant 1—6 weeks later at a local health centre by 
centrally-trained doctors and nurses. Each participant’s height, weight, 
and body circumference were measured, and fasting blood samples for 
serum lipids and glucose were taken from the participants. Details of the 
methodology of the project have been published elsewhere [93-94]. 
 
4.3.3 Home blood pressure and home heart rate 
measurements (Studies II—V) 
 
Home BP and HR were self-measured with a validated, automatic 
oscillometric device (Omron model HEM-722C; Omron Corp., Tokyo 
Japan) [95]. Participants received written instructions and individual 
guidance on how to measure BP and HR correctly. Seated BP and HR 
were measured twice, approximately at a 2-min interval every morning 
between 0600 and 0900 h (before breakfast and washing) and every 
evening between 1800 and 2100 h on 7 consecutive days. Study 
participants were informed to avoid smoking (or other tobacco-containing 
products), caffeine-containing products, heavy physical exercise and 
eating before measurements. Before the measurements, study participants 
were instructed to sit in a straight chair by a table for at least 10 min, with 
a BP monitoring cuff wrapped around the upper arm for at least 5 min. 
Home BP and HR were determined as the mean of 14 duplicate 
measurements (28 measurements). A sum of 86.3% of the study 
population had complete home monitoring data (all 28 measurement 
points). Ninety-eight percent of the study population had at least 14 
monitoring points. The mean number of home BP and HR measurements 
were 26.7 ± 3.7 (Study II) and 27.0±2.8. (Studies III-V). 
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4.3.4 Office blood pressure measurements (Study III) 
 
Office BP was measured by a nurse with a conventional and calibrated 
mercury sphygmomanometer from the sitting individual’s right arm after 
10 min of rest. The last 5 min of rest were spent in the measuring room 
with the cuff around the upper right arm. BP was measured using a 
pressure cuff of appropriate size and methods that were in accordance 
with current guidelines [96]. Systolic and diastolic BP were defined 
according to Korotkoff sounds I and V. The means of two measurements 
performed at a 2-min interval were used to determine office BP. 
 
4.3.5 ECG measurements (Study III) 
 
Standard resting 12-lead ECGs were digitally recorded by using a 
Marquette MAC 5000 device and stored as digital data on a Marquette 
MUSE CV 5B system (Marquette Hellige, Milwaukee, WI, USA). All 
ECGs were overread, and the measurements corrected if needed, by a 
single physician experienced with ECG before being stored into the 
database. ECG-left ventricular hypertrophy (LVH) was assessed with 
Cornell product ([RaVL+SV3] x QRS duration, plus 6 mm for women) [97], 
because it had the highest correlation with home BP [98]. 
 
4.3.6 Definitions 
 
Diabetes mellitus was defined as a fasting serum glucose level higher or 
equal to 7.0 mmol/l (one measurement was available) or the use of insulin 
injections, oral hypoglycaemic agents or both (Anatomical Therapeutic 
Chemical (ATC) codes A10A and A10B). Presence of 
hypercholesterolemia was defined as a fasting serum total cholesterol 
level higher or equal to 7.0 mmol/l, or the use of lipid modifying agents 
ATC code C10A). Smoking was defined as current use of tobacco 
products (yes or no). Alcohol intake was evaluated with a questionnaire 
and the amount of alcoholic drinks was converted to grammes of absolute 
ethanol. Because of the large portion of abstinent participants (n=577, 
30%), alcohol consumption (g/week) was divided into three groups 
according to international recommendations [99-100]. The first group 
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included the participants who did not use alcohol, the second group 
included men using over zero and less than or equal to 280 g/week and 
women over zero and less than or equal to 140 g/week and the third group 
included men using over 280g/week and women over 140g/week, 
respectively. 
 
A questionnaire was used to define the occurrence of sleep apnea 
according to following criteria (Studies III and IV) [101]. If the answer to 
the question ‘Do you snore when sleeping? (Ask others if you are not 
sure)’ was ‘yes’, then the following additional questions were addressed: 
‘How often do you snore’?, ‘What does your snoring sound like? (Ask 
others if needed)’ and ‘Have you noticed (or have others noticed) 
respiratory pauses when you sleep’?. Sleep apnea was considered 
probable, if snoring was loud and irregular, with occasional respiratory 
pauses, stertorous breathing or both; and respiratory pauses with a 
frequency of at least 1—2 nights weekly. Using these criteria, apnea was 
found in 179 participants (10%). 
 
The selection to normal, prehypertensive and hypertensive category was 
made by office BP measurements according to Joint National Committee 
7 (JNC-7) criteria [10] (Study III). Stage 1 and stage 2 hypertension 
categories were combined as one hypertension category. 
 
A history of CV disease was defined as having at least one of the 
following: past history of angina pectoris, heart infarction or stroke. In 
addition to these, previous percutaneous coronary intervention or 
coronary artery bypass graft surgery was also included in the history of 
CV disease in Study V. Information on previous myocardial infarction, 
coronary heart disease, strokes, percutaneous coronary intervention or 
coronary artery bypass graft surgery was obtained from hospital discharge 
summaries that study participants brought along, or from the National 
Hospital Discharge Register. 
 
4.3.7 Follow-up 
 
The follow-up data were accumulated until December 31, 2008 (Study V), 
and until December 31, 2007 (Study II). Mortality data were obtained 
from the national mortality register based on death certificates. The 10th 
version of the International Classification of Diseases, Injuries, and 
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Causes of Death (ICD-10) was used in classification. ICD-10 codes I21-
I25 (chronic or acute ischemic heart disease), I61 (intracerebral 
hemorrhage), I63 (cerebral infarction), I46 (cardiac arrest), I11 
(hypertensive heart disease), I71.3 (ruptured abdominal aortic aneurysm), 
and I70.2 (atherosclerosis of extremity arteries) were classified as CV 
deaths. 
Data on hospitalization due to heart failure and non-fatal coronary and 
stroke events were obtained from the national hospital discharge register. 
Non-fatal CV events included the following events: ICD-10 codes I21-23 
(acute coronary events), I61 and I63 (acute stroke events), and I50 
(hospitalized due to acute heart failure). In addition, the performed 
coronary interventions and coronary artery bypass-graft surgeries were 
obtained from the hospital discharge register. The Finnish hospital 
discharge register and national mortality register data have been validated 
on stroke and coronary heart disease diagnoses [102-103]. 
The primary endpoint was the combination of CV mortality, non-fatal 
myocardial infarction, nonfatal stroke, hospitalization for heart failure, 
percutaneous coronary intervention, and coronary artery bypass surgery. 
Only the first event was included in the analysis. The secondary end-point 
was total mortality.  
 
4.3.8 Statistical analyses 
 
The variability of home BP and HR are calculated as the SD of daily 
morning minus evening measurements of 7 consecutive days (morning—
evening home BP and HR variability), as the SD of daily BP mean of 7 
consecutive days (day-by-day home BP and HR variability) and as the SD 
of all the first minus second measurements (1st—2nd measurement of 
home BP and HR variability) (Figure 3). The skewed distributions of all 
home BP variability and HR variability variables were log-transformed 
for the analyses. Pearson’s correlation was used to assess the relationship 
between home BP and HR variability and continuous variables. Student’s 
t-test was used to compare the between-group differences in home BP and 
HR variability. Analysis of variance was used to compare home BP and 
HR variability between groups divided by alcohol consumption. 
Statistically significant variables in the univariate analyses were included 
in the multivariate linear regression analysis (Studies III and IV). 
The Cox proportional hazards’ model was used to test the association 
between CV events and individual covariates (age, gender, BMI, home 
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BP/home HR, presence of diabetes, current smoking, use of alcohol, 
presence of hypercholesterolemia, past history of CV disease and use of 
antihypertensive medication) (Study V). The Cox proportional hazards’ 
model was used as well for prognostic multivariate analyses (Studies II 
and V). Association of home BP variability and home HR variability with 
the end-points were analysed by estimation of the relative hazard ratios 
(RH) and their 95% confidence interval (CI) per 1 mmHg or 1 beat/min 
increase in the variability of BP or HR (Study V). The prognostic models 
were adjusted for age, gender, BMI, home BP/home HR, presence of 
diabetes, current smoking, use of alcohol, presence of 
hypercholesterolemia, past history of CV disease and use of 
antihypertensive medication (Study V). The likelihood ratio !2 value was 
used as a measure of goodness of fit between the model containing a 
single BP index and the model containing 2 indices (Study II). A 
significant likelihood ratio !2 indicates that the index represents a 
significantly stronger association with CV events (Study II). 
Statistical analyses were performed using SAS software, version 9.1 (SAS 
Institute, Cary, North Carolina, USA. A p-value of less than 0.05 was 
considered statistically significant. 
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5 Results 
5.1 Optimal schedule for home blood pressure 
monitoring (I and II) 
 
5.1.1 Characteristics of home blood pressure during 7 
consecutive days of measurement (I) 
 
Mean evening systolic/diastolic home BP was 3.7/1.2 mmHg higher than 
mean morning home BP (p<0.001 for both). The mean of the first 
systolic/diastolic home BP measurements on each measurement occasion 
was 2.3/1.2 mmHg higher (p<0.001 for both) than the mean of the second 
measurements. BP averaged over days 2 through to 7 was only 0.2/0.1 
mmHg lower (p<0.001/0.02) than BP averaged over the days 1 through to 
7. There was a slight decreasing trend in both systolic and diastolic BP 
from the first day to the third measurement day (Table 2/Study I). 
 
5.1.2 Association between home blood pressure and 
ambulatory blood pressure (I) 
 
The correlation between home BP and ambulatory BP increased slightly 
with the cumulative number of home measurements. No major increase in 
the correlations occurred after day 4 (Table 3, Figure 1/Study I). The 
correlation between home BP and ambulatory BP was not significantly 
higher when the first day of the measurements was excluded from the 
mean of all measurements (r=0.89/0.87 vs. r=0.89/0.87 for 
systolic/diastolic home BP, p=0.25/0.39). 
 
There were no significant differences in the correlations between 
systolic/diastolic ambulatory BP and the mean of first (r=0.89/0.87) or 
second home BP (r=0.89/0.87) measurements performed on each 
measurement occasion. No significant differences were found in the 
correlations between systolic/diastolic ambulatory BP and morning 
(r=0.87/0.85) or evening (r=0.88/0.87) home BP (p=0.29/0.12). 
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5.1.3 Association between home blood pressure and target 
organ damage (I) 
 
The correlations between home BP and left ventricular mass index 
(LVMI) or urine microalbumin increased slightly with the cumulative 
number of home BP measurement days (Table 3, Figure 1/Study I). No 
major increase in the correlations occurred after day 4. The correlation 
between systolic/diastolic home BP and LVMI or urine microalbumin 
was not higher when the first day of the measurement was excluded 
(r=0.62/0.60 vs. r=0.62/0.60 for LVMI, p=0.26/0.10 and r=0.34/0.33 vs. 
0.34/0.33, p=0.39/0.75 for urine microalbumin). The correlations between 
LVMI and the mean of the first (r=0.61/0.60) or the second home BP 
(r=0.62/0.59) measurements taken on each measurement occasion were 
equally strong (p=0.72/0.06). The same applied for urine microalbumin 
(r=0.33/0.33 vs. r=0.34/0.32, p=0.09/0.55). Both the systolic/diastolic 
morning home BP measurements (r=0.62/0.60) correlated slightly better 
than the evening home BP measurements (r=0.59/0.57) with LVMI 
(p=0.03/0.01). No significant differences were detected in the correlations 
between urine microalbumin and systolic/diastolic morning (r=0.34/0.33) 
or evening (r=0.33/0.31) home BP (p=0.70/0.40). 
 
The results were similar in both hypertensive and normotensive 
populations (data not shown). 
 
5.1.4 Association between home blood pressure and 
cardiovascular events (II) 
 
Subjects who had suffered a CV event during the follow-up had 
significantly higher mean home BPs obtained during the morning of the 
first measurement day (1-morning, number of measurements=2), the first 
measurement day (1-day, n=4), the first two measurement days (2-day, 
n=8), days 2 to 7 (days 2-7, n=24), the whole week (1-week, n=28), the 
morning measurements (morning, n=14), the evening measurement 
(evening, n=14), the first measurements of each measurement occasion 
(first measurement, n=14), and the second measurements of each 
measurement occasion (second measurement, n=14) than those who had 
not (Table 2/Study II). 
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All BP variables (shown in Figures 1 and 2/Study II) were predictive of 
total CV risk (p<0.001 for all). Figure 1/Study II shows that the predictive 
value of home BP increased progressively with the cumulative number of 
measurements and the greatest predictive value was achieved by using the 
mean of all measurements (systolic/diastolic hazard ratio per 1 mmHg 
increase in BP, 1.021/1.034; systolic/diastolic 95% confidence interval 
[CI], 1.012-1.030/1.018-1.049). However, most of the increase in 
predictive value occurred during the first three days of measurement (RH, 
1.017/1.028; 95% CI, 1.009-1.026/1.013-1.045). The predictive value also 
showed an increasing trend when individual measurement days were 
analysed separately, but this trend weakened after the third day of 
measurement, especially for diastolic BP (Figure 1/Study II). 
 
The first measurement, second measurement, morning, evening, 7-day, 
and days 2-7 were all predictive of CV risk (p<0.001 for all, Figure 
2/Study II). Table 3/Study II shows the likelihood ratio !2 values when 
two BP indices were analysed simultaneously. When the first day of 
measurement was discarded, no additional benefit was achieved. The 
second measurement on each measurement occasion increased slightly 
the goodness-of-fit as compared with the model that included only the 
first measurements, but only with systolic BP. A model which compared 
the predictive values of the first measurement of each measurement 
occasion (14 measurements) with the measurements taken during the first 
three and a half days (14 measurements) was as well used in this study. 
There was no increase in the goodness-of-fit for systolic BP (p=0.26), but 
a slight increase for diastolic BP (p=0.03). Adding evening BP to the 
model which included morning BP did not result in a greater goodness-of-
fit. 
 
The correlations between home BP and target organ-damage, and the 
predictive values between home BP and cardiovascular events, in 
different measurement settings have been compared in Table 4. 
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Table 4. The correlations/predictive values between home BP and target- 
organ damage/CV events in different measurement settings 
 Target organ damage*  
Measurement 
days 
Ambulatory 
BP LVMI 
Microalbumin-
uria CV events† 
Day 1 0.84/0.82 0.56/0.55 0.30/0.30 1.014/1.019 
Days 1-3 0.88/0.85 0.59/0.58 0.33/0.32 1.017/1.028 
Days 2-7 0.89/0.87 0.62/0.60 0.34/0.33 1.021/1.038 
Days 1-7 0.89/0.87 0.62/0.60 0.34/0.33 1.021/1.034 
          
*The Pearson correlation between systolic/diastolic home BP and target-organ 
damage  
†Predictive values between systolic/diastolic home BP and CV events 
BP, blood pressure; CV, cardiovascular   
 
5.2 Factors affecting the difference between morning 
and evening home blood pressure (III) 
 
5.2.1 Morning and evening home blood pressure level in study 
subjects with and without antihypertensive medication 
 
In untreated hypertensive subjects, systolic home BP was lower in the 
morning than in the evening while no difference was detected in diastolic 
home BP (137.7/85.1 vs. 141.5/85.2 mmHg, p<0.001/0.64). In treated 
hypertensive subjects, the difference between systolic morning and 
evening BP was smaller (136.2 vs. 137.1 mmHg, p=0.023) and diastolic 
morning BP was even higher than evening BP (83.3 vs. 82.1 mmHg, 
p<0.001). 
 
5.2.2 Associations between selected clinical variables and the 
morning-evening home blood pressure difference 
 
In the univariate analysis, higher home BP and higher BMI were 
associated with relatively higher systolic and diastolic morning home BP 
compared with evening BP (Table 3/Study III). Higher age was associated 
with relatively higher diastolic morning home BP compared with evening 
BP, whereas no association was found between age and systolic morning 
and evening home BP difference. In addition, men, subjects with CV 
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disease, sleep apnea, excessive alcohol use, and subjects using 
antihypertensive medication had relatively higher morning BP compared 
with evening BP. Smokers had higher diastolic evening home BP 
compared with morning BP than non-smokers (Table 3/Study III), and 
they were also younger than non-smokers (53.4±7.2 vs. 57.4±8.7 years, 
p<0.001). Morning-evening home BP difference was not associated with 
the Cornell product [97-98] in the whole study population, in men or 
women (data not shown), either in treated or untreated subjects (data not 
shown). 
 
5.2.3 Independent determinants of the morning-evening home 
blood pressure difference 
 
In the multivariate linear regression analysis male gender, the use of 
antihypertensive medication, the presence of sleep apnea, a past history of 
CV disease and excessive use of alcohol were all independent 
determinants of elevated systolic and diastolic morning home BP 
compared with evening BP (Table 4/Study III). Smoking was an 
independent determinant of an elevated diastolic evening home BP 
compared with morning BP, and high BMI an independent determinant of 
an elevated diastolic morning home BP compared with evening BP (Table 
4/Study III). The independent determinants affecting morning-evening 
home BP difference are presented in Table 5. 
 
Table 5. Independent determinants of morning-evening home blood 
pressure difference 
 Morning BP higher than evening BP 
Determinant systolic/diastolic (mmHg) 
Male gender 0.21/1.91 
Subjects using antihypertensive medication 1.03/2.05 
Subjects with sleep apnea 0.38/1.83 
Subjects with past history of CV disease 0.47/1.92 
Subjects with excessive alcohol consumption 1.13/2.48 
BP, blood pressure; CV, cardiovascular  
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5.3 Factors affecting the variability of home-
measured blood pressure and heart rate (IV) 
 
The mean values of the variability variables in home-measured BP and 
HR are presented in Table 1/Study IV. The distribution of home BP 
variability is presented in Figure 1/Study IV and home HR variability in 
Figure 2/Study IV. 
 
5.3.1 Determinants of home blood pressure variability 
 
Univariate associations of home blood pressure variability 
Old age, high home BP, high BMI, use of antihypertensive medication, 
CV disease and diabetes were associated with greater systolic and 
diastolic morning minus evening, day-by-day and first minus second 
measurement of home BP variability (Table 2/Study IV). There were 
significant differences between alcohol usage groups in morning minus 
evening, day-by-day and first minus second measurement of home BP 
variability (Table 2/Study IV). Smoking and sleep apnea were not 
associated with any of the home BP variability variables. 
 
Morning minus evening home blood pressure variability 
Old age, past history of CV disease, diabetes and high systolic/diastolic 
home BP were independent determinants of both greater systolic and 
diastolic morning minus evening home BP variability (Table 3/Study IV). 
Female sex, low BMI and excessive use of alcohol were independent 
determinants of greater systolic morning minus evening home BP 
variability. 
 
Day-by-day home blood pressure variability 
Old age, high systolic/diastolic home BP and excessive use of alcohol 
were independent determinants of both greater systolic and diastolic home 
day-by-day BP variability (Table 3/Study IV).  
The use of antihypertensive medication, high home HR, low BMI and 
being of the female sex were independent determinants of greater systolic 
day-by-day home BP variability. CV disease and smoking were 
independent determinants of greater diastolic day-by-day home BP 
variability. When day-by-day home BP variability was divided into 
morning and evening components, the associations were almost similar, 
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except for excessive use of alcohol, which was not associated with 
systolic morning day-by-day variability (data not shown). 
 
The variability of first minus second home blood pressure 
measurement 
Old age, female sex, high systolic/diastolic home BP and CV disease 
were independent determinants of both greater systolic and diastolic first 
minus second measurement of home BP variability. High home HR and 
excessive use of alcohol were independent determinants of systolic first 
minus second measurement of home BP variability, and high BMI and 
diabetes were independent determinants of diastolic first minus second 
measurement of home BP variability. 
5.3.2 Determinants of home heart rate variability 
 
Univariate associations of home heart rate variability 
High home HR, young age, absence of antihypertensive medication and 
smoking were associated with greater morning minus evening, day-by-
day and first minus second measurement of home HR variability (Table 
2/Study IV). Sleep apnea was associated with lower morning minus 
evening and first minus second measurements of home HR variability. 
Moreover, high diastolic home BP was associated with greater morning 
minus evening and day-by-day home HR variability. There were 
significant differences between the alcohol usage groups in morning 
minus evening, day-by-day and first minus second measurement of home 
HR variability. 
 
Morning minus evening home heart rate variability 
A younger age-group, high home HR, absence of sleep apnea and 
moderate use of alcohol were independent determinants of greater 
morning minus evening home HR variability (Table 4/Study IV). 
 
Day-by-day home heart rate variability 
Being of a younger age-group, high home HR, high diastolic home BP 
and use of alcohol were independent determinants of greater day-by-day 
home HR variability (Table 4/Study IV). When day-by-day home HR 
variability was divided between the morning and evening components, 
the associations were almost similar, except for smoking and excessive 
use of alcohol, which were independent determinants of greater morning 
day-by-day variability (data not shown). 
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The variability of first minus second home heart rate 
measurement 
Being of a younger age-group, female sex and high home HR were 
independent determinants of greater first minus second measurement of 
home HR variability (Table 4/Study IV). 
 
5.3.3 Coefficient of variation 
 
When the coefficient of variation was used as a measure of variability 
instead of SD, the results of the variability in home-measured day-by-day 
BP and HR were mainly similar (data not shown). Variances explained by 
the multivariate models were lower when the coefficient of variation was 
used instead of SD (data not shown). 
 
A summary of the independent determinants of the home BP variability 
and home HR variability are presented in Table 6. 
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Table 6. Independent determinants of home blood pressure variability 
and home heart rate variability. 
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5.4 Prognostic value of the variability in home-
measured blood pressure and heart rate (V) 
 
Baseline variability of home BP and HR in the study population with or 
without a CV event during the follow-up are reported in Table 3/Study V. 
Home BP variation was higher in subjects who had suffered a CV event 
than in healthy subjects. On the contrary, no difference was detected in 
home HR variability variables between the two groups. 
 
5.4.1 Home blood pressure variability and home heart rate 
variability as predictors of cardiovascular events 
 
In the unadjusted Cox regression models, all the home BP variability 
variables, but none of the home HR variability variables were predictive 
of CV events (Table 1s/Study V). After adjustments for other risk factors, 
both systolic and diastolic morning minus evening home BP variability 
and morning day-by-day home BP variability remained as independent 
predictors of CV events (Table 4/Study V). Diastolic day-by-day and first 
minus second measurement of home BP variability were equally 
predictive of CV events. In contrast, morning minus evening HR 
variability and morning day-by-day HR became predictors of CV events 
in the adjusted models. More specifically, morning-evening HR 
variability and morning day-by-day HR variability both became 
predictive of CV events after age was added as the only covariate in the 
models (for morning-evening HR variability RH, 1.08; 95% CI, 1.04-1.13; 
p=0.01, per 1 beat/min increase in HR variability, and for morning day-
by-day HR variability RH, 1.11; 95% CI, 1.06-1.17; p=0.002, per 1 
beat/min increase in HR variability). 
 
In the subgroup analyses of strokes, only diastolic first minus second 
measurement of home BP variability was predictive of stroke events (RH, 
1.13; 95% CI, 1.03-1.25; p=0.042, per 1 mmHg increase in BP variability) 
in the adjusted model. None of the home HR variability measurements 
predicted strokes (data not shown). 
 
5 - Results 
THL  –- Research 66 58 Home BP and home HR monitoring 
 
5.4.2 Home blood pressure variability and home heart rate 
variability as predictors of total mortality 
 
In the unadjusted Cox regression models, all home BP variability 
variables, as well as morning minus evening and morning day-by-day 
variables of home HR variability predicted total mortality (Table 3/Study 
V). 
In the adjusted models, all the other diastolic home BP variability 
variables, except diastolic evening day-by-day home BP variability, were 
predictive of all-cause mortality (Table 4/Study V). Systolic morning day-
by-day home BP variability was the only systolic home BP variability 
predictor of all-cause mortality. Moreover, morning-evening and morning 
day-by-day home HR variability variables were predictive of all-cause 
mortality in the adjusted models. 
 
5.4.3 The additive effect of home blood pressure variability 
and home heart rate variability as predictors of cardiovascular 
events 
 
The cumulative risk between CV events and morning systolic/diastolic 
home BP variability, as well as the CV risk between home HR variability 
at different BP levels are presented in Figure 1/Study V. The cumulative 
risk between CV events and home HR variability at different HR levels 
was not clinically meaningful since home HR level itself was not 
associated with CV events (p=0.70). 
 
When systolic/diastolic morning day-by-day home BP variability was 
adjusted for morning day-by-day home HR variability and for other CV 
risk covariates used in Table 4/Study V, systolic/diastolic morning home 
BP variability did not remain as an independent determinant of CV events. 
The same result was found when systolic morning minus evening home 
BP was adjusted for morning minus evening home HR variability and 
other CV risk covariates. When diastolic morning minus evening home 
BP variability was adjusted for morning minus evening HR variability 
and other CV risk covariates, diastolic morning minus evening home BP 
variability remained as an independent determinant (RH=1.08; 95% CI, 
1.03-1.13, p=0.02 per 1 mmHg increase in BP variability). 
When morning day-by-day home HR variability was adjusted for 
systolic/diastolic morning home BP variability and other CV risk 
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covariates, morning home HR variability remained as an independent 
determinant for CV events (RH=1.10; 95% CI, 1.04-1.16, p=0.009 per 1 
beat/min increase in HR variability adjusted for systolic morning BP 
variability, and RH=1.08; 95% CI, 1.02-1.15, p=0.02 adjusted for 
diastolic morning BP variability). When morning minus evening home 
HR variability was adjusted for systolic/diastolic morning minus evening 
home BP variability and other CV risk covariates, it did not reach 
statistical significance. 
The additive effect of diastolic morning home BP variability and morning 
home HR variability for CV risk at different home BP levels is presented 
in Figure 2/Study V. 
 
5.4.4 Coefficient of variation 
 
Using the coefficient of variation instead of SDs of day-by-day and 
morning/evening day-by-day home BP and home HR produced similar 
results, in both unadjusted and adjusted models (data not shown). 
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6 Discussion 
6.1 Optimal schedule for home blood pressure 
monitoring (I and II) 
6.1.1 Optimal schedule for home blood pressure measurement 
based on the correlation with target-organ damage and 
ambulatory blood pressure 
 
Home BP decreased gradually to a near-plateau level as the individuals 
became accustomed to home BP measurements. This has been 
demonstrated in previous studies as well [40, 104-105].  
 
The correlations of home BP with target-organ damage and ambulatory 
BP increased with the cumulative number of measurement days, although 
no major increase occurred after day 4. Maximal correlations were 
achieved when all 28 measurements were used. There was no change in 
the correlations when the measurements performed during the first day 
were discarded. 
 
The associations of home BP with ambulatory BP and microalbuminuria 
were equally strong when home BP was measured in the morning and in 
the evening and small, clinically insignificant difference was detected for 
LVMI. These results suggest that there might not be any difference 
whether morning or evening measurements are used in the evaluation of 
CV risk. However, measuring both morning and evening home BP is 
important for assessing the 24-h efficacy of antihypertensive treatment 
[70-72]. 
 
The mean of the second home BP measurements on each measurement 
occasion was lower than the mean of the first measurements. This finding 
may suggest that individuals measuring home BP are more anxious 
during the first measurements and therefore, home BP level obtained in 
the second measurements better represents the true BP level. This finding 
emphasized the importance of rest before performing home BP 
measurements. The first measurements should not be discarded because 
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including both first and second measurements resulted in the highest 
correlations. 
 
As home BP decreased, the association between home BP and ambulatory 
BP or target-organ damage increased. Therefore, the number of the 
measurements seems to be the most important factor in measuring home 
BP. Most of the decrease in home BP and increase in correlations 
occurred during the first 4 days of the measurements. The results were 
similar in both hypertensive and normotensive populations. 
 
6.1.2 Optimal schedule for home blood pressure measurement 
based on future cardiovascular events 
 
The predictive value of home BP increases progressively with the number 
of measurements, showing the highest predictive value with the average 
of all measurements performed during one week. However, a clear 
majority of this increase is achieved during the first three days of 
measurement. No additional benefit in predictive ability is achieved when 
the values obtained during the first day of measurement are discarded. 
Morning and evening BP are equally predictive of future CV events. 
Measurement of home BP twice, instead of once, on each measurement 
occasion offers a marginally better predictive value as it doubles the 
number of measurements, but only with systolic BP. 
 
It has been previously demonstrated by the Ohasama group that the 
predictive value for stroke risk associated with home BP increases 
progressively within the range of 1–14 measurements performed during 
one week without any clear threshold [43]. This study, with 28 
measurements performed during one week, also demonstrates that the 
predictive value of home BP increases progressively with the number of 
measurements, showing the highest predictive value with the average of 
all measurements performed during one week. However, a clear majority 
of this increase is achieved during the first three days of measurement and 
only minimal increase occurs after day 6. These data confirm previous 
cross-sectional findings demonstrating that the correlation between home 
BP and hypertensive target-organ damage increases slightly but steadily 
over a one-week home BP measurement period, and that only marginal 
increase occurs after the sixth day of measurement (Study I) [98, 106].  
Measurement of home BP preferably for a period of seven days, or for at 
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least three days, is therefore needed to obtain a thorough image of a 
patient’s true BP level. 
 
The current guidelines recommend from one to three measurements on 
each occasion, although the two largest epidemiological studies have been 
performed with just one home BP measurement on each occasion [22, 49, 
64, 69]. The recommendations of the European and American guidelines 
are mostly based on the evidence that regression to the mean during 
consecutive measurements on each occasion is frequently observed even 
after long-term monitoring [107]. However, the Japanese Society of 
Hypertension guidelines for self-monitoring of BP at home recommend at 
least one measurement on each occasion without denying that multiple 
measurements might be of value, but this recommendation is based 
mostly on pure speculation according to which it would be more 
convenient and result in better compliance [85]. In our study, the second 
measurement produced on average 3/1 mmHg lower BP values than the 
first measurement and it increased the predictive value of systolic BP. 
Furthermore, 14 measurements measured twice on seven occasions seem 
to provide additional predictive value over 14 measurements performed 
once on 14 occasions. The Finn-home study demonstrates that performing 
two measurements on each occasion does not result in poor compliance 
since the study subjects measured their BP on average 27 times out of the 
28 possible. However, this was an epidemiological study without a 
doctor-patient relationship and self-reported BP readings. In real-life 
clinical practice, adherence to measurements might not be as good as 
those observed in our study. Although the raw number of measurements 
seems to be the most important factor in determining predictive value, 
home BP should be measured twice on each occasion because of a lower 
number of required measurement days, a slightly better predictive ability, 
and the regression to the mean effect. 
 
Results from the Ohasama study and our study suggest that discarding the 
first day of measurements could not necessarily be applicable from the 
viewpoint of prognostic significance [108]. Due to the large overlap in the 
mean BP for days 1-7 and days 2-7, the significance of the first day is 
quite miniscule. 
 
The differences in morning and evening home BP in the general 
population are quite small, under 2 mmHg [43, 104, 109]. This study and 
a previous study by the Ohasama group also demonstrate that morning 
and evening home BP seem to provide equally useful information for CV 
6 - Discussion 
THL  –- Research 66 63 Home BP and home HR monitoring 
 
risk [110]. However, antihypertensive treatment alters the difference 
between morning and evening BP, and morning hypertension might be a 
slightly better predictor of stroke risk among individuals using 
antihypertensive medication (Study III) [104, 110]. An analysis of such a 
kind was not performed in this study due to the small number of events 
among the treated hypertensives (n=63). Thorough morning home BP 
measurements and evening measurements can also be used effectively for 
assessing the duration of antihypertensive drug action in patients [70, 72]. 
Home measurements in the morning and in the evening are therefore 
recommended for obtaining a thorough image of the average BP and to 
evaluate the round-the-clock efficacy of antihypertensive medication. 
 
6.1.3 Consensus for optimal schedule for home blood 
pressure measurement 
 
Current European guidelines [49] recommend discarding home BP 
measurements made on the first day since higher and more unstable 
values are usually obtained during the first home BP measurements [104, 
107-108]. This phenomenon has been shown in studies on selected 
hypertensive populations [62, 107], and it appears to be present also in the 
population as a whole [104, 108]. The plateau level that is reached in BP 
with an increasing number of home BP measurements, as the patient 
becomes acquainted with home measurement, could therefore best 
represent the subjects’ “true” BP level. 
Based on this thesis, the correlations of home BP with ambulatory BP 
(Study I) and target-organ damage (Study I) [98, 106], and the predictive 
power of home BP measurements on CV events (Study II), no additional 
benefit was attainable if the values obtained during the first day of the 
measurements were discarded, even when only 12 measurements were 
available. Discarding the home BP values of the initial day makes the 
measurement schedule more complex for the patient and the treating 
physician. Furthermore, the alerting reaction seen during the first days of 
the initial measurement week will most likely attenuate during the 
following week-long measurement sessions. Therefore, the first day of the 
measurements should be included in the measurement schedule. 
 
In conclusion, based on this study, it can be recommended that home BP 
should be measured on at least 4 days and preferably on 7 days, with 
duplicate measurements in the morning and in the evening. The first and 
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second measurements on each measurement occasion should be included 
along with the values obtained during the first day of measurements. 
 
6.2 Factors affecting the difference between morning 
and evening home blood pressure (III) 
 
6.2.1 Quantitative differences between morning and evening 
home blood pressure 
 
Evening home BP was higher than morning home BP (Study III, Table 1 
and 2), which is in accordance with studies performed in Europe [39-42]. 
However, in Japanese studies, morning BP is consistently higher than 
evening BP [43-46] which could be attributed to the differences between 
Japanese and European studies. The Japanese guidelines recommend 
measuring evening home BP before going to bed [85], whereas in this 
study and in the other European studies, home BP was measured at a 
fixed time, usually a few hours before going to bed. Furthermore, it has 
been shown that the evening measurements in Japan are often performed 
after taking a hot bath, which lowers BP by vasodilatation [45, 111]. 
 
6.2.2 Morning and evening home blood pressure in treated 
and in untreated subjects 
 
In untreated hypertensive subjects, systolic home BP was lower in the 
morning than in the evening while no difference was detected for diastolic 
home BP (Study III, Table 2). In treated hypertensive subjects, the 
difference between systolic morning and evening BP was smaller. 
Conversely, diastolic morning BP was even higher than evening BP. 
When the study population was classified according to JNC-7 criteria, 
hypertensive subjects had higher systolic and diastolic morning BP 
compared with evening BP than prehypertensive or normotensive subjects. 
No significant difference was detected in the morning BP compared with 
evening BP between normotensive and prehypertensive groups. 
The smaller difference between morning and evening home BPs in treated 
subjects, which was also observed in the Hypertension Optimal Treatment 
(HOT) study [112], is most likely explained by the fact that the study 
subjects were instructed to measure morning home BP before taking their 
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antihypertensive medication. Antihypertensive medication is usually 
taken once a day, typically in the morning [113]. The peak of the 
antihypertensive effect is seen in the evening which balances the 
difference between morning and evening BP. Home BP monitoring has 
been shown to provide a good alternative to ambulatory monitoring for 
obtaining a precise and unbiased evaluation of 24-h antihypertensive drug 
effect [70-72].  
 
6.2.3 Qualitative differences between morning and evening 
home blood pressure 
 
Male gender, excessive use of alcohol, use of antihypertensive medication, 
a past history of CV disease and sleep apnea were independent 
determinants of elevated morning home BP compared with evening BP.  
 
Alcohol 
Excessive use of alcohol was an independent determinant for an elevated 
morning BP compared with evening BP. Subjects using excessive 
amounts of alcohol had their morning BP at a higher level than non-
alcohol and moderate alcohol users. In addition, subjects moderately 
taking alcohol had a lower BP level (morning and evening) than non-
alcohol users. Despite this observation, no difference was detected in the 
morning-evening difference between moderate users and zero users. A 
small amount of alcohol seems therefore not to affect the difference 
between morning and evening home BP. 
In general, alcohol intake causes BP to decrease during the first few hours, 
while thereafter increasing it, this resulting in a higher BP level [7]. The 
acute BP decrease (in the hours after exposure) is due to vasodilation and 
is followed by BP elevation (next day) which is caused by sympathetic 
nervous activity [7]. Since alcohol is usually consumed in the evenings, 
this results in a relatively lower evening BP and higher morning BP [7, 
56]. The finding in this study is in accordance with previous Japanese 
studies in which regular alcohol drinking was an independent determinant 
of an elevated morning BP compared with evening BP [44-45]. 
 
Sleep apnea 
Sleep apnea is a very common disease and its prevalence is 4% among 
men and 2% among women in middle-aged adults [114]. Epidemiological 
studies have also revealed that obstructive sleep apnea is a risk factor for 
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developing hypertension [115]. In our study, sleep apnea was 
independently associated with an elevated morning home BP compared 
with evening BP. This finding is most likely explained by the fact that 
apneic sleep elevates BP and results in an elevated morning home BP 
compared with evening BP [48]. A similar finding has been previously 
found in one study [116]. Since sleep apnea continues to be an important 
public health care issue, a high morning home BP compared with evening 
BP could be used to identify subjects suffering from it. 
 
Past history of cardiovascular disease 
A past history of CV disease was also independently associated with an 
elevated morning home BP compared with evening BP. In subjects with 
CV disease, impairment of cerebral autoregulation has been put forward 
as a cause for morning surge (elevated morning BP) [117]. Elevated 
morning home BP compared with evening BP was seen in subjects with 
CV disease. Nonetheless, LVH, estimated by using the Cornell product, 
was not associated with greater morning home BP compared with evening 
BP. This may imply that some factors other than cardiac-based target-
organ damage (measured by ECG-LVH) are responsible for an elevated 
morning home BP compared with evening BP. However, providing a 
reason for this finding requires further study. 
 
Gender 
Male gender was an independent determinant of an elevated morning 
home BP compared with evening BP, which is in accordance with the 
findings in the Japanese Ohasama study [43]. Several potential 
differences between men and women, such as BP regulating hormones, 
may partly explain the elevated morning home BP compared with 
evening BP. In addition, lower morning home BP compared with evening 
BP in females also leaves room for examining the different types of stress 
load during the day in men and women [118], i.e. females may have more 
additional work with the family in the evening, which might elevate their 
evening BP. However, the precise physiological causes for this 
phenomenon remain unknown and warrant further study. 
 
 
Smoking and body mass index 
Non-smoking was an independent determinant of an elevated diastolic 
morning home BP compared with evening BP, although study subjects 
were instructed to avoid smoking for 1 h before performing the home BP 
measurements. In addition, smokers were younger than non-smokers. 
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Therefore, our study finding suggests that daytime smoking may elevate 
evening home BP. This elevation in BP is thought to be partly mediated 
through the stimulation of sympathetic nervous system consequently 
leading to an increased plasma norepinephrine and epinephrine levels [8]. 
The pressor effect of smoking caused by nicotine (stimulating release of 
norepinephrine) is transient and is over after 30 minutes [8]. On the other 
hand, smoking impairs nitric oxide dependent vasodilation by increasing 
oxidative stress and plasma asymmetric dimethyl arginine (nitric oxide 
synthase inhibitor) levels, leading to elevated BP [119]. High BMI (>30 
kg/m2) was also an independent determinant of an elevated diastolic 
morning home BP compared with evening BP. Our finding is in 
accordance with a study where overweight subjects were likely to have a 
reduced nocturnal fall in BP, which is seen in our study as an elevated 
diastolic morning BP [120]. 
 
6.2.4 Morning and evening home blood pressure 
measurements in clinical practice 
 
This study suggests that both morning and evening home BP should be 
used to assess the mean BP load, especially in subjects using 
antihypertensive medication. Awareness of the patient’s elevated morning 
home BP compared with evening BP enables physicians to evaluate the 
24-h efficacy of antihypertensive treatment. In addition, these results 
provide physicians with better knowledge of the factors affecting the 
elevated morning home BP compared with evening BP and help them 
understand the underlying causes. Physicians could thus find the 
appropriate treatment (adjust antihypertensive medication or further 
examine probable sleep disorder), and recommend lifestyle adjustments 
(alcohol and CV disease prevention counseling) that will be effective for 
individual patients. 
 
6.3 Factors affecting the variability of home-
measured blood pressure and heart rate (IV) 
 
This study assessed for the first time the factors affecting the variability 
of home BP and HR in a general population using ESH home 
measurement recommendations. 
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6.3.1 Determinants of home blood pressure variability 
 
Age 
Old age was independently associated with greater morning minus 
evening, day-by-day and first minus second measurement of home BP 
variability. This can be attributed to the increased arterial stiffness due to 
age-related changes in contents of the arterial vessel wall (elastin is 
replaced by collagen), which magnifies BP changes and, therefore, 
increases variability [121-122]. 
 
Diabetes 
Moreover, diabetes was an independent determinant of greater morning 
minus evening home BP variability. Hyperglycemia also affects the 
arterial vessel wall proteins and leads to arterial stiffening and a higher 
home BP variability [123]. 
 
Home blood pressure level 
In addition, elevated BP level remained as an independent determinant for 
greater morning minus evening, day-by-day and first minus second 
measurement of home BP variability, which can be attributed to the 
greater magnitude of BP variation at higher levels of BP.  
 
Cardiovascular disease 
CV disease was, as well, an independent determinant of greater morning 
minus evening and first minus second measurements of home BP 
variability. More specifically, CV disease was an independent 
determinant of greater first minus second measurement of home BP 
variability only in women, in older participants (aged 56 years or over) of 
both sexes and in participants using antihypertensive medication. The 
association between CV events and greater short-term and day-by-day BP 
variability has been found in prognostic studies as well [55, 60]. 
 
Alcohol consumption 
Excessive use of alcohol was an independent determinant for greater 
systolic and diastolic day-by-day, and in addition, systolic morning minus 
evening and first minus second measurements of home BP variability. In 
the subgroup analyses, the association between the greater home BP 
variability and use of alcohol was especially seen in men, which might be 
due to higher consumption of alcohol in men. In Finland, the peak of the 
alcohol consumption is concentrated on the last days of the week (Friday 
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and Saturday), whereas on the other days, the consumption is lower [124]. 
Alcohol intake causes BP to decrease during the first few hours (due to 
vasodilatation) and, thereafter increases it (due to sympathetic nervous 
activation, resulting in a positive net effect [7]. Excessive use of alcohol 
could, therefore, increase home BP variability by increasing sympathetic 
activity [125-126] and by elevating BP [127]. This could be seen in the 
present study as a greater variability between measurement days and also 
between measurement occasions. 
 
6.3.2 Determinants of home heart rate variability 
 
Alcohol consumption 
Excessive and moderate uses of alcohol were independent determinants of 
greater day-by-day home HR variability, whereas moderate use of alcohol 
was an independent determinant of greater morning minus evening home 
HR variability. More specifically, the use of alcohol was an independent 
determinant of greater morning minus evening home HR variability, only 
in younger participants (aged 55 years or less) and in women. Alcohol 
drinking leads to vasodilatation (for a few hours), and next day to an 
increased sympathetic activity (leading to elevated HR) [125-126]. This is 
seen in our study as a greater home HR variability between measurement 
days, especially in excessive users of alcohol. The same effect, which is 
seen in BP variation, is also present in HR variation. That is, alcohol 
consumption is concentrated unevenly between the weekdays (the peak in 
consumption is seen on Friday and Saturday) [124], which may contribute 
to greater home HR variability between measurement days in excessive 
users of alcohol. In moderate users (especially in women and younger 
participants), the effect of alcohol is rather seen in greater morning minus 
evening HR variability than in greater day-by-day variability. 
 
Smoking 
Study participants were instructed to avoid smoking for 1 h before 
performing the home BP and HR measurements. Despite this fact, in the 
univariate analysis, smoking was associated with greater morning minus 
evening, day-by-day and first minus second measurements of home HR 
variability, but in the multivariate models adjusted with home HR level, 
smoking was not an independent determinant. This might be partly 
because smoking elevates HR by stimulation of the sympathetic nervous 
system, leading to an increased plasma norepinephrine and epinephrine 
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levels [8], but does not increase the actual home HR variability. The 
pressor effect of smoking caused by nicotine (stimulating release of 
norepinephrine) might be also missed in BP monitoring since it is over by 
30 minutes [8, 128]. On the other hand, smoking impairs nitric oxide 
dependent vasodilation by increasing oxidative stress and plasma 
asymmetric dimethyl arginine (nitric oxide synthase inhibitor) levels, 
leading to elevated HR [119]. 
 
Age 
A younger age was, as well, an independent determinant of greater 
morning minus evening, day-by-day and first minus second 
measurements of home HR variability. Furthermore, in subgroup analyses, 
use of alcohol was an independent determinant of greater home HR 
variability only in younger participants (aged 55 years or less). This is 
obvious as younger people have more adaptable and effective baroreflex 
buffering, which is seen as an increased home HR variability between 
measurement days and measurement occasions [51]. 
 
6.3.3 The variability of home-measured blood pressure and 
heart rate in clinical practice 
 
Old age, diabetes, CV disease and excessive use of alcohol may increase 
home BP variability, and on the contrary, a younger age and use of 
alcohol may increase home HR variability. As home BP variability and 
home HR variability have prognostic significance, it is important for 
physicians to understand the underlying causes of home-measured BP and 
HR variability. In this way, they can focus on alcohol, diabetes and CV 
disease-prevention counselling for their high-risk patients. 
 
6.4 Prognostic value of the variability in home-
measured blood pressure and heart rate (V) 
 
The value of BP and HR monitoring is not only limited to their absolute 
level, since high variability of BP and HR in ambulatory recordings have 
been associated with target-organ damage and CV events [51-55, 57, 59]. 
This study addressed for the first time the prognostic implications of the 
variability in home-measured BP and HR in European population and has 
compared the prognostic value of the variability in home-measured BP 
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and HR in different measurement settings (morning-evening, day-by-day, 
morning/evening day-by-day and first minus second measurement of 
variability). 
 
6.4.1 Home blood pressure variability as a predictor of 
cardiovascular events 
 
The association between higher home BP variability and CV events may 
partly reflect underlying disease states. In the cross-sectional study of the 
variability in home-measured BP and HR (Study IV), diabetes and a past 
history of CV disease were independent determinants of higher home BP 
variability. Aging and diabetes hasten the arterial stiffening process 
leading to changes in contents of the arterial vessel wall (elastin is 
replaced by collagen) [121-122]. This can magnify BP changes and 
increase BP variability. 
Morning day-by-day home BP variability predicted CV events whereas 
evening day-by-day BP variability did not. The prevalence of CV 
complications has been shown to be higher in the morning than at other 
times of the day [117, 129]. This has been linked to the activation of  the 
sympathetic nervous system [130] and to an increase in platelet 
aggregability [129]. Higher morning day-by-day home BP variability may 
therefore reflect greater hemodynamical instability and exposure to CV 
events. Higher morning-evening home BP variability also predicted CV 
events which supports the theory of greater hemodynamical instability in 
subjects at risk of CV events. In the Japanese Ohasama study day-by-day 
home BP variability (measured in the morning) was predictive of CV 
mortality which is in accordance with our study [60]. 
However, in the Ohasama study day-by-day home BP variability was also 
predictive of stroke mortality, whereas in our study home day-by-day BP 
variability did not predict strokes. This may be partly attributed to the 
differences between study populations, and, in addition, to the smaller 
number of strokes in our study. 
 
Diastolic first minus second measurement of home BP variability 
predicted CV events (Table 4). This variability variable can be generally 
considered to indicate better short-time variability than the other home 
variability variables, since there is only a gap of a few minutes between 
the measurements. Therefore, greater first minus second measurement of 
home BP variability indicates the reactivity of an individual, seen as a 
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high variation of BP between the measurement occasions.  The link 
between the reactivity and high variation between measurement occasions 
might be explained by the autonomic nervous system activation and 
arterial baroreflex since short-term alteration in BP is regulated primarily 
by these two factors [117]. 
 
6.4.2 Home heart rate variability as a predictor of 
cardiovascular events 
 
Morning day-by-day home HR variability predicted CV events in the 
fully adjusted models, whereas home evening day-by-day HR variability 
did not (Table 4). Moreover, the variability of morning home HR and 
morning-evening home HR were predictive of CV events in the fully 
adjusted models but not in unadjusted models (Tables 3 and 4). Age was 
the primary covariate to explain this. As shown in our previous study 
(Study IV), being of a younger age was an independent determinant of 
greater home HR variability. Including age as a covariate in the analyses, 
indicates that especially older subjects with high HR variation are at the 
greatest risk of a CV event, since older people generally are more likely 
to have an underlying CV disease, which could lead to hemodynamic 
instability seen as fluctuations in HR. 
In addition, morning home HR variability predicted CV events 
independently of morning home BP variability. However, home HR level 
was not predictive of CV events. This was a surprising finding since in 
the Japanese Ohasama study home HR predicted CV mortality in general 
population [131]. The association between higher morning day-by-day 
HR variability and CV events may reflect as well a greater 
hemodynamical instability due to impairment in cerebral autoregulation 
[117]. Hemodynamical instability can be as well the underlying cause in 
the association between greater variability of morning-evening home HR 
and CV events. In the Japanese Ohasama-study where home 
measurements were performed once every morning, day-by-day home HR 
variability was, as in our study, predictive of CV mortality although in the 
Ohasama study morning and evening HR variability was not separately 
examined [60]. None of the home HR variability measurements were 
predictive of stroke events in our study. The similar finding was also 
made in the Ohasama study where home HR variability did not predict 
stroke mortality. 
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6.4.3 Prognostic value of the variability in home-measured 
blood pressure and heart rate in clinical practice 
 
This prospective study provides first evidence that higher morning-
evening and morning day-by-day home BP and HR variability predicts 
CV events. Moreover, morning day-by-day home HR variability 
predicted CV events independently of morning day-by-day home BP 
variability. 
Hypertensive subjects with increased variability of BP and HR should 
therefore be identified as high-risk patients. In addition to measurement of 
home BP and HR levels, we should encourage physicians to use the 
variability of home BP and HR when assessing the CV risk of a 
hypertensive patient. 
 
6.5 Prognostic value of morning and evening 
difference in home blood pressure and home heart 
rate 
 
Greater difference between morning and evening home HR was 
predictive of CV events in the multivariate model, whereas such an 
association between morning and evening home BP was not found. This 
might be explained by the fact that the average BP level itself, rather than 
the relatively higher morning BP compared with evening BP, is the most 
important factor in the development of a CV event. 
Instead, greater morning home HR compared with evening HR was an 
independent predictor of CV events in the multivariate model. This might 
be due to impaired baroreflex buffering [51] leading to higher morning 
HR in subjects at risk of a CV disease. 
6.6 Benefits of home blood pressure and home heart 
rate monitoring 
 
As the home measurements of BP and HR provide a reliable method for 
assessing the true BP and HR level of an individual, they provide also an 
enormous amount of data of the BP and HR level at different time-points 
throughout the day and between days. 
When performed according to guidelines, measurement of BP and HR at 
home provides a reliable tool for physicians to assess an individual’s 
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health status. Home BP and home HR level combined with the 
information of morning and evening home BP, as well as with the 
variability of home-measured BP and HR can provide valuable 
information for physicians working in clinical practice.  
6.7 Limitations of the current international guidelines 
of home blood pressure monitoring 
 
Although the current home BP monitoring guidelines provide a good 
basis to perform reliable home BP measurements, they are still far from 
excellent. As home BP monitoring can provide additional information, 
beyond the basic BP level, such as the value of different measurement 
settings and the variability of home BP and HR, the current guidelines do 
not answer to any of these questions. Until now, the reason for this has 
been the lack of knowledge concerning factors affecting morning and 
evening home BP difference, and factors affecting the difference of home 
BP variability variables, as well as the prognostic value of home BP 
variability. 
 
6.8 Future applications of home blood pressure 
monitoring and its economical benefits 
 
In this thesis, the optimal schedule for home BP monitoring was 
determined. Based on the data of target-organ damage and CV outcome 
home BP measurements should be performed preferably for a period of 7 
days, but at least on three days, including morning and evening 
measurements (for reliable assessment of antihypertensive drug action). 
The most important goal in the near future is to get the data gathered from 
home measurements to be applied effectively in clinical practice. In 
addition to the conventional home BP and home HR level, the morning 
and evening measurements, as well as, the variability of home measured 
BP and HR should be taken into account in clinical practise. 
Computer-aided technologies could be used to collect and interpret data 
from measurements more efficiently. This includes, collecting and 
gathering data from home-measurements into repositories so as to be 
easily applicable by physicians.  
 
Computer-aided technology can provide a great help in home BP 
monitoring and data acquiring. In the future, the data gathered from 
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individual home BP monitors can easily be delivered to physicians by 
using e.g. wireless networks. All the technology needed is already 
available, but the current problem is its integration into the practical 
solutions. Based on the home measurements, and other health 
examination data, automated computerized models could calculate the CV 
risk for an individual. However, to perform reliable CV risk calculations 
more studies are needed to model the overall CV risk. This information 
achieved from the future studies could be applied to build a universal CV 
risk model to be used by physicians in primary health care. 
 
Home BP monitors with embedded wireless technology and integration 
into the physicians' database also makes enormous savings by offering an 
easy and reliable way of delivering home BP data from patient to 
physician and by providing a smooth access to home BP monitoring data 
history. This saves both the time of the patient and the physician and 
further improves the measurement compliance of the patient. 
 
6.9 Unresolved issues in home-measured blood 
pressure and heart rate measurements 
 
Although a lot of effort has already gone into making home BP 
monitoring more reliable and effective, there are still some tasks to be 
undertaken. The main objective is to build a unified model for home BP 
monitoring to be used in primary health care units and in the home. This 
includes not only the utilization of home BP and home HR level itself, but 
also the utilization of information gathered from morning and evening 
measurements and the variability measurements of home BP and home 
HR. Combining this home measurement data with other health 
information of the individual makes it possible to get a more thorough 
‘image’ of the individual’s current health status. 
As important as is the optimal utilization of home BP monitoring data, an 
accurately performed home BP/HR monitoring is at least of the same 
importance. There are already validation protocols available for home 
monitors [36], which set the minimum standard for home BP monitors. 
The problem with the current validation protocol is that the protocol takes 
into account validation only at the population level but does not make any 
validation at the individual level [38]. This means that with the current 
validation protocol a home BP monitor may be more accurate for some 
individuals than for others. At the moment, the individual consumer or a 
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health care professional has to count on the current protocol 
recommendations when choosing a home BP monitor. 
6.10 Study limitations 
6.10.1 Study I 
 
The strength of the study is that it is based on clinical data instead of on 
statistical models in trying to define the best schedule for home BP 
measurements. Despite the clinical approach in trying to define the best 
schedule for home BP measurement, this study is still lacking the 
prognostic approach. A larger population-based follow-up study to assess 
the optimal schedule for home BP measurement is, therefore, needed. 
6.10.2 Study II 
 
Participants measured their BP under relatively controlled conditions, and 
received individual guidance on how to perform the measurements 
correctly. However, it is still possible that measurement procedure could 
have affected BP level. No information was available about the 
compliance of home BP measurements which could have given a more 
thorough image of the validity of the measurements made. 
6.10.3 Study III 
 
Because of the cross-sectional nature of this study, no cause – effect 
relationships can be drawn from our findings. In addition, the timing of 
taking antihypertensive medication, smoking or the use of alcohol was not 
controlled. Either we did not have data available about the history of 
hypertension, nor the history of how long the study-subjects had been 
using antihypertensive medication. Having this information available 
could have given a more thorough view of the effects of these 
determinants on an elevated morning home BP compared with evening 
BP. 
 
6.10.4 Study IV 
 
Because of the cross-sectional nature of this study, no cause–effect 
relationships can be drawn from our findings. The prognostic values of 
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home BP variability and HR variability remain to be determined in future 
studies. 
 
6.10.5 Study V 
 
Although the home BP and HR measurements were carefully assessed the 
study results must be interpreted with caution. The interview data and 
laboratory measurements were gathered at the baseline of the study, and 
therefore the possible changes in the persons’ health status were not 
updated during the follow-up. Participants measured their BP and HR 
under relatively controlled conditions, and received individual guidance 
on how to perform the measurements correctly. However, it is still 
possible that measurement procedure could have affected BP variability. 
Even though this study assessed the prognostic value of the variability in 
home-measured BP and HR based on the CV outcome, additional 
research is warranted for examining whether CV prognosis can be 
improved by making lifestyle adjustments (e.g. reducing alcohol 
consumption and giving CV disease prevention counselling). This 
remains to be assessed in future studies. 
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7 Conclusions 
This thesis was set out to provide insight into building an optimal 
measurement schedule for home BP monitoring, and to evaluate how to 
increase the prognostic value of home measurements by using variability 
parameters of home BP and HR measured over several days. 
  
Based on the risk for target-organ damage (increased left ventricular mass 
and microalbuminuria) and future cardiovascular events, the measurement 
accuracy increased progressively with a cumulative number of 
measurements and the greatest value was achieved by using the mean of 
all measurements. Most of the increase occurred during the first 3 days of 
measurement. In contrast to what the European guidelines (2008) suggest,  
the measurements performed during the first day should not be discarded, 
as it makes the measurement schedule more complex for the patient and 
the treating physician. Currently, a great deal of conflict exists in the 
recommended home BP schedules in various international guidelines, and 
no agreement on this matter has yet been reached. Therefore, the novel 
information of this thesis could be used to prepare a unified international 
guideline for home BP measurements. 
 
In addition, the measurement of home BP and home HR over 7 days can 
provide additional information since the variability of home BP and home 
HR has predicted future CV events. 
In the general population, evening home BP was higher than morning 
home BP. In untreated hypertensive subjects, systolic home BP was lower 
in the morning than in the evening, while no difference was detected for 
diastolic home BP. In treated hypertensive subjects, the difference 
between systolic morning and evening BP was smaller. Conversely, 
diastolic morning BP was even higher than evening BP. Male gender, 
excessive use of alcohol, use of antihypertensive medication, past history 
of CV disease and sleep apnea were independent determinants of elevated 
systolic and diastolic morning home BP compared with evening BP. 
Having a knowledge of the underlying causes affecting morning and 
evening home BP difference in patients enables physicians to make 
possible medication and lifestyle adjustments. Physicians could find the 
appropriate treatment (adjust antihypertensive medication or further 
examine probable sleep disorder), and recommend lifestyle adjustments 
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(alcohol and CV disease prevention counselling) that will be effective for 
individual patients. 
 
Old age, diabetes, CV disease and excessive use of alcohol were 
independently associated with increased home BP variability. Young age 
and use of alcohol were independently associated with increased home 
HR variability. As especially the variability of morning and morning-
evening home BP and home HR are both independently associated with 
future CV events, it is important for physicians to understand the 
underlying causes of the variability in home-measured BP and HR. In this 
way, they can focus on alcohol, diabetes and CV disease prevention 
counselling for their patients. 
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